(214051, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0030153', 'dental pulp inflammation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214052, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011467', 'decreased urine urea nitrogen level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214053, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0000313', 'abnormal cell death', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214054, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004836', 'abnormal synaptic acetylcholine release', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214055, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004587', 'decreased cellular sensitivity to X-ray irradiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214056, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214057, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003897', 'abnormal ST segment', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214058, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0000503', 'excessive digestive secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214059, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0030574', 'increased hair follicle cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214060, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214061, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001915', 'intracranial hemorrhage', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214062, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010654', 'slow Wallerian degeneration', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214063, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004415', 'abnormal cochlear nerve compound action potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214064, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002634', 'abnormal sensorimotor gating', 0.6086956521739131, 7.291997705654976, 2.1068002513514026, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214065, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002294', 'short gestation period', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214066, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011925', 'abnormal heart echocardiography feature', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214067, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010752', 'impaired mucociliary clearance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214068, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0009643', 'abnormal urine homeostasis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214069, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003823', 'increased left ventricle developed pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214070, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0020974', 'abnormal FO-wave shape', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214071, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0012124', 'increased bronchoconstrictive response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214072, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0006001', 'abnormal intestinal transit time', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214073, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008272', 'abnormal endochondral bone ossification', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214074, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010954', 'abnormal cellular respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214075, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214076, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0020002', 'increased response to antigen', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214077, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0005036', 'diarrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214078, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003464', 'abnormal single cell response threshold', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214079, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214080, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0009475', 'abnormal nicotine-mediated receptor currents', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214081, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008669', 'increased interleukin-12b secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214082, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0021022', 'decreased adipose tissue noradrenaline turnover', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214083, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0013752', 'stridor', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214084, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0012035', 'abnormal b-wave shape', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214085, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0012261', 'increased hindbrain apoptosis', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214086, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002920', 'decreased paired-pulse facilitation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214087, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002292', 'abnormal gestational length', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214088, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003469', 'decreased single cell response intensity', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214089, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0014030', 'abnormal mucous gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214090, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003725', 'increased autoantibody level', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214091, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002906', 'increased susceptibility to pharmacologically induced seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214092, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0014027', 'abnormal respiratory epithelial chloride transmembrane transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214093, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214094, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003088', 'abnormal prepulse inhibition', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214095, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214096, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0012382', 'abnormal blood cell physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214097, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0000947', 'convulsive seizures', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214098, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0005004', 'abnormal lymphocyte anergy', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214099, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010560', 'intraventricular block', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214100, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011417', 'abnormal renal transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214101, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003219', 'increased spike-wave discharge type II', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214102, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010748', 'abnormal visual evoked potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214103, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0014183', 'increased respiratory epithelial sodium ion transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214104, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008566', 'increased interferon-gamma secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214105, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003699', 'abnormal female reproductive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214106, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214107, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0012032', 'abnormal ERG latency', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214108, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214109, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010510', 'absent P wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214110, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011219', 'abnormal intestinal calcium absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214111, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008403', 'decreased cellular sensitivity to alkylating agents', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214112, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002194', 'maximal tonic hindlimb extension seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214113, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214114, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214115, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001899', 'absent long-term depression', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214116, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214117, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0020414', 'abnormal fibroblast physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214118, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0013639', 'decreased bone stiffness', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214119, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008407', 'decreased cellular sensitivity to hydrogen peroxide', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214120, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004877', 'abnormal systemic vascular resistance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214121, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0000948', 'nonconvulsive seizures', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214122, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010505', 'abnormal T wave', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214123, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002136', 'abnormal kidney physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214124, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008700', 'decreased interleukin-4 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214125, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004486', 'decreased response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214126, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001627', 'abnormal cardiac output', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214127, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001761', 'abnormal urination pattern', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214128, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0009348', 'abnormal urine pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214129, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010571', 'shortened ST segment', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214130, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003252', 'abnormal bile duct physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214131, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0012556', 'increased cell death', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214132, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004558', 'delayed allantois development', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214133, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0031484', 'increased urine hypoxanthine level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214134, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008687', 'increased interleukin-2 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214135, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011271', 'prolonged excitatory postsynaptic current rise time', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214136, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214137, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008840', 'abnormal spike wave discharge', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214138, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003203', 'increased neuron apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214139, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002195', 'psychomotor seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214140, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214141, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0014179', 'abnormal blood-retina barrier function', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214142, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0014132', 'abnormal tear film physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214143, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003186', 'abnormal redox activity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214144, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001921', 'reduced fertility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214145, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011518', 'abnormal cell chemotaxis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214146, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002912', 'abnormal excitatory postsynaptic potential', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214147, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008413', 'decreased cellular sensitivity to oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214148, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214149, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214150, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0012040', 'abnormal c-wave shape', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214151, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002893', 'ketoaciduria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214152, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0005044', 'sepsis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214153, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0009645', 'crystalluria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214154, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214155, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0005620', 'abnormal muscle contractility', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214156, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001934', 'increased litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214157, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003868', 'abnormal feces composition', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214158, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008663', 'increased interleukin-12 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214159, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0009244', 'abnormal acid-activated cation-mediated receptor currents', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214160, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003393', 'decreased cardiac output', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214161, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001800', 'abnormal humoral immune response', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214162, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008679', 'decreased interleukin-16 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214163, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0006190', 'retina ischemia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214164, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0031066', 'cytokine storm', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214165, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011274', 'short excitatory postsynaptic current decay time', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214166, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214167, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003298', 'choking', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214168, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0009058', 'decreased interleukin-21 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214169, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004417', 'decreased cochlear nerve compound action potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214170, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003259', 'nausea', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214171, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214172, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010515', 'abnormal Q wave', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214173, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008001', 'hypochlorhydria', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214174, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0005447', 'abnormal synaptic norepinephrine release', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214175, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0014178', 'increased brain apoptosis', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214176, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002999', 'abnormal bone healing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214177, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0006053', 'hypothalamus hemorrhage', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214178, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0013561', 'abnormal endocrine gland physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214179, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0031126', 'gangrene', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214180, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0014042', 'decreased cellular sensitivity to DNA damaging agents', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214181, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0021010', 'impaired synaptic physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214182, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214183, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011931', 'abnormal pulmonary valve flow', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214184, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008711', 'increased interleukin-9 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214185, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0030129', 'tongue inflammation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214186, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002471', 'abnormal complement pathway', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214187, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0000740', 'impaired smooth muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214188, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0013136', 'genital discharge', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214189, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214190, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214191, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0031482', 'abnormal urine hypoxanthine level', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214192, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011951', 'increased cardiac stroke volume', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214193, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0009350', 'decreased urine pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214194, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214195, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003899', 'abnormal QT interval', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214196, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0005043', 'defective assembly of class II molecules', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214197, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011043', 'abnormal lung elastance', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214198, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010050', 'hypermyelination', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214199, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0013634', 'increased femur fracture load', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214200, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008544', 'impaired olfaction', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214201, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0000738', 'impaired muscle contractility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214202, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008260', 'abnormal autophagy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214203, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001986', 'abnormal taste sensitivity', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214204, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0030987', 'spinal cord inflammation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214205, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010504', 'abnormal RR interval', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214206, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003997', 'tonic-clonic seizures', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214207, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010386', 'abnormal urinary bladder physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214208, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001337', 'dry eyes', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214209, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011273', 'prolonged excitatory postsynaptic current decay time', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214210, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0020137', 'decreased bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214211, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003116', 'rickets', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214212, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010895', 'increased lung compliance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214213, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004807', 'abnormal paired-pulse inhibition', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214214, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004149', 'increased bone strength', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214215, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214216, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001912', 'increased cerebrospinal fluid production', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214217, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214218, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0009046', 'muscle twitch', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214219, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001835', 'abnormal antigen presentation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214220, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0006114', 'cardiac murmur', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214221, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.6086956521739131, 7.291997705654976, 2.1068002513514026, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214222, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008411', 'decreased cellular sensitivity to ultraviolet irradiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214223, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002917', 'decreased synaptic depression', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214224, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004085', 'abnormal heartbeat', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214225, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003193', 'decreased cholesterol efflux', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214226, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0014157', 'alacrima', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214227, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214228, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214229, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0031127', 'dry gangrene', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214230, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0020039', 'increased bone ossification', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214231, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214232, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0031091', 'hypogeusia', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214233, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003880', 'abnormal central pattern generator function', 0.6086956521739131, 7.291997705654976, 2.1068002513514026, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214234, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0021016', 'decreased tau protein phosphorylation', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214235, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0000920', 'abnormal myelination', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214236, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0013555', 'abnormal apocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214237, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214238, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0012697', 'abnormal maternal body weight gain', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214239, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001846', 'increased inflammatory response', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214240, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214241, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0013134', 'poor circulation in autopods', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214242, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0020219', 'increased tear production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214243, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.6086956521739131, 7.291997705654976, 2.1068002513514026, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214244, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0006046', 'atrioventricular valve regurgitation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214245, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011047', 'increased lung tissue damping', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214246, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214247, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0012034', 'abnormal a-wave shape', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214248, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0006388', 'abnormal auditory summating potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214249, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010377', 'abnormal gut flora balance', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214250, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001663', 'abnormal digestive system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214251, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011465', 'abnormal urine urea nitrogen level', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214252, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0012197', 'impaired myofibroblast differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214253, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0030939', 'abnormal autophagosome formation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214254, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001924', 'infertility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214255, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002578', 'impaired ability to fire action potentials', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214256, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0020040', 'decreased bone ossification', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214257, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0031302', 'syncope', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214258, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008817', 'hematoma', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214259, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0013570', 'abnormal neuroendocrine gland physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214260, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002914', 'abnormal endplate potential', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214261, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011758', 'renal ischemia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214262, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003009', 'abnormal cytokine secretion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214263, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010896', 'decreased lung compliance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214264, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214265, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003900', 'shortened QT interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214266, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004227', 'increased cellular sensitivity to ionizing radiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214267, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0013637', 'increased femur stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214268, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0030909', 'abnormal melanocyte adhesion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214269, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008682', 'decreased interleukin-17 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214270, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004875', 'increased mean systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214271, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003484', 'abnormal channel response', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214272, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004811', 'abnormal neuron physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214273, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002322', 'abnormal respiratory transport', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214274, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003927', 'increased cellular glucose import', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214275, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003490', 'decreased channel response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214276, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004010', 'increased diastolic filling velocity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214277, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214278, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0000423', 'delayed hair regrowth', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214279, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0031111', 'meningoencephalitis', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214280, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011927', 'abnormal cardiac valve flow', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214281, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0031332', 'abnormal inhibitory postsynaptic current amplitude', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214282, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002945', 'abnormal inhibitory postsynaptic currents', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214283, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004925', 'decreased susceptibility to noise-induced hearing loss', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214284, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214285, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010368', 'abnormal lymphatic system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214286, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0031471', 'abnormal micropinocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214287, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0000751', 'myopathy', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214288, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004037', 'increased muscle relaxation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214289, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003157', 'impaired muscle relaxation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214290, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008670', 'decreased interleukin-12b secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214291, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003256', 'biliary cirrhosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214292, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0005647', 'abnormal sex gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214293, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010636', 'bundle branch block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214294, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004183', 'abnormal sympathetic nervous system physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214295, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011926', 'abnormal heart valve physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214296, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004878', 'increased systemic vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214297, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0006152', 'tunnel vision', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214298, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011068', 'abnormal ependyma motile cilium physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214299, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0020412', 'abnormal amnion physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214300, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011221', 'decreased intestinal calcium absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214301, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010680', 'abnormal skin adnexa physiology', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214302, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004736', 'abnormal distortion product otoacoustic emission', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214303, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010994', 'aerophagia', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214304, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0009057', 'increased interleukin-21 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214305, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011928', 'abnormal mitral valve flow', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214306, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0020155', 'enhanced humoral immune response', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214307, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0030940', 'impaired autophagy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214308, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0012565', 'perivasculitis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214309, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0000064', 'failure of bone resorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214310, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0031215', 'abnormal response to myocardial ischemic injury', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214311, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002207', 'abnormal long-term potentiation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214312, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003889', 'enhanced sensorimotor gating', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214313, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0009762', 'abnormal mitotic spindle assembly checkpoint', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214314, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008410', 'increased cellular sensitivity to ultraviolet irradiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214315, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0000316', 'cellular necrosis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214316, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0021015', 'increased tau protein phosphorylation', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214317, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0030938', 'abnormal reticulophagy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214318, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004008', 'abnormal GABA-mediated receptor currents', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214319, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003041', 'increased time of onset of induced ischemic contracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214320, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214321, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002335', 'decreased airway responsiveness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214322, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003375', 'abnormal menstrual cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214323, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214324, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011002', 'enhanced AMPA-mediated synaptic currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214325, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001793', 'abnormal susceptibility to infection', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214326, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0005621', 'abnormal cell physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214327, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008703', 'decreased interleukin-5 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214328, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0030991', 'optic nerve inflammation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214329, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004859', 'abnormal synaptic plasticity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214330, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0006143', 'increased systemic arterial diastolic blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214331, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0020000', 'abnormal response to antigen', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214332, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0012111', 'failure of morula compaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214333, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214334, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008706', 'decreased interleukin-6 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214335, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0012503', 'increased midbrain apoptosis', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214336, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0012554', 'increased serum complement activity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214337, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003901', 'abnormal PR interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214338, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0006080', 'brain ischemia', 0.6086956521739131, 7.291997705654976, 2.1068002513514026, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214339, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0031098', 'abnormal sputum production', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214340, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0005087', 'decreased acute inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214341, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214342, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003635', 'abnormal synaptic transmission', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214343, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214344, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0013145', 'eye discharge', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214345, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0000352', 'decreased cell proliferation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214346, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0005410', 'abnormal fertilization', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214347, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001727', 'abnormal embryo implantation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214348, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0031104', 'crackles', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214349, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214350, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008708', 'increased interleukin-7 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214351, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001876', 'decreased inflammatory response', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214352, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001598', 'abnormal blood viscosity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214353, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003077', 'abnormal cell cycle', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214354, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0012201', 'decreased endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214355, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001664', 'abnormal digestion', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214356, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011069', 'abnormal brain ependyma motile cilium physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214357, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0000951', 'sporadic seizures', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214358, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011048', 'decreased lung tissue damping', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214359, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0005576', 'decreased pulmonary ventilation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214360, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0006264', 'decreased systemic arterial systolic blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214361, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008004', 'abnormal stomach pH', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214362, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0006044', 'tricuspid valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214363, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002876', 'abnormal thyroid gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214364, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0000351', 'increased cell proliferation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214365, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002327', 'abnormal respiratory function', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214366, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214367, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002921', 'abnormal post-tetanic potentiation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214368, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001935', 'decreased litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214369, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002314', 'abnormal respiratory mechanics', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214370, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010653', 'abnormal Wallerian degeneration', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214371, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008006', 'increased stomach pH', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214372, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002090', 'abnormal vision', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214373, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011900', 'podocyturia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214374, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001902', 'reduced NMDA-mediated synaptic currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214375, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008145', 'hemeralopia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214376, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214377, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004050', 'abnormal renal sympathetic nerve activity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214378, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0005167', 'abnormal blood-brain barrier function', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214379, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001847', 'brain inflammation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214380, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0014182', 'decreased respiratory epithelial sodium ion transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214381, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0009668', 'ectopic pregnancy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214382, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0031223', 'increased CXCL10 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214383, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010155', 'abnormal intestine physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214384, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001499', 'abnormal kindling response', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214385, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0031169', 'abnormal joint physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214386, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008069', 'abnormal joint mobility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214387, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003674', 'oxidative stress', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214388, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0013625', 'increased femur yield load', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214389, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010511', 'shortened PR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214390, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004513', 'avnosmia', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214391, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0014043', 'decreased cellular sensitivity to cisplatin', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214392, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214393, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0030215', 'facial muscle fasciculation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214394, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008688', 'decreased interleukin-2 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214395, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003463', 'abnormal single cell response', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214396, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001378', 'abnormal ejaculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214397, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214398, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0012745', 'abnormal neural crest cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214399, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002420', 'abnormal adaptive immunity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214400, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003487', 'increased channel response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214401, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008558', 'abnormal interferon-beta secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214402, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214403, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010993', 'decreased surfactant secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214404, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002988', 'decreased urine osmolality', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214405, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008705', 'increased interleukin-6 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214406, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214407, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003878', 'abnormal ear physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214408, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004773', 'abnormal bile composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214409, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008696', 'increased interleukin-3 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214410, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.6086956521739131, 7.291997705654976, 2.1068002513514026, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214411, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0031334', 'increased inhibitory postsynaptic current amplitude', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214412, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003220', 'decreased spike-wave discharge type II', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214413, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214414, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002796', 'impaired skin barrier function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214415, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0005645', 'abnormal hypothalamus physiology', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214416, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010055', 'abnormal sensory neuron physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214417, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002922', 'decreased post-tetanic potentiation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214418, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011832', 'abnormal visual acuity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214419, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011804', 'increased cell migration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214420, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0005076', 'abnormal cell differentiation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214421, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214422, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001819', 'abnormal immune cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214423, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002915', 'abnormal synaptic depression', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214424, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010028', 'aciduria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214425, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004494', 'abnormal synaptic glutamate release', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214426, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011045', 'decreased lung elastance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214427, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002206', 'abnormal CNS synaptic transmission', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214428, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004011', 'decreased diastolic filling velocity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214429, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002193', 'minimal clonic seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214430, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001916', 'intracerebral hemorrhage', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214431, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001909', 'reduced NMDA receptor mediated synaptic activity in barrel cortex', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214432, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0009562', 'abnormal odor adaptation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214433, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001933', 'abnormal litter size', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214434, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214435, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0000743', 'muscle spasm', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214436, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0000921', 'demyelination', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214437, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214438, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004070', 'abnormal P wave', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214439, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003089', 'decreased skin tensile strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214440, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003690', 'abnormal glial cell physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214441, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001596', 'hypotension', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214442, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003547', 'abnormal pulmonary pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214443, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214444, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0013210', 'abnormal primary cilium physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214445, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003480', 'increased nerve fiber response intensity', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214446, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214447, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0006263', 'decreased systemic arterial diastolic blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214448, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0031221', 'abnormal CXCL10 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214449, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0020142', 'increased anti-sperm antibody level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214450, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004738', 'abnormal auditory brainstem response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214451, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001951', 'abnormal breathing pattern', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214452, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008712', 'decreased interleukin-9 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214453, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003260', 'vomiting', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214454, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0014254', 'increased paired-pulse ratio', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214455, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0021023', 'increased adipose tissue noradrenaline turnover', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214456, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214457, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003467', 'abnormal single cell response intensity', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214458, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010552', 'abnormal HV interval', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214459, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0030573', 'abnormal hair follicle cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214460, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008664', 'decreased interleukin-12 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214461, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214462, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214463, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002916', 'increased synaptic depression', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214464, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011952', 'decreased cardiac stroke volume', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214465, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011987', 'abnormal GABAergic neuron physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214466, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004211', 'abnormal sour taste sensitivity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214467, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004216', 'salt-resistant hypertension', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214468, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008007', 'abnormal cellular replicative senescence', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214469, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002161', 'abnormal fertility/fecundity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214470, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0006048', 'pulmonary valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214471, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002498', 'abnormal acute inflammation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214472, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008412', 'increased cellular sensitivity to oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214473, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003122', 'maternal imprinting', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214474, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214475, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0000327', 'hemosiderinuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214476, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008744', 'abnormal B cell anergy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214477, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010741', 'abnormal melanocyte proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214478, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010992', 'increased surfactant secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214479, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001636', 'irregular heartbeat', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214480, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003481', 'decreased nerve fiber response intensity', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214481, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0031013', 'abnormal egg activation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214482, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214483, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003621', 'dysuria', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214484, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0014040', 'increased cellular sensitivity to DNA damaging agents', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214485, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003191', 'abnormal cellular cholesterol metabolism', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214486, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008672', 'increased interleukin-13 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214487, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0020154', 'impaired humoral immune response', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214488, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0012029', 'abnormal electroretinogram waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214489, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0006138', 'congestive heart failure', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214490, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003123', 'paternal imprinting', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214491, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003483', 'decreased nerve fiber response threshold', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214492, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0030924', 'early exit from telogen phase', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214493, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004768', 'abnormal axonal transport', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214494, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0012006', 'abnormal hippocampus physiology', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214495, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008567', 'decreased interferon-gamma secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214496, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214497, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001790', 'abnormal immune system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214498, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003482', 'increased nerve fiber response threshold', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214499, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003865', 'lymph node inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214500, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0005330', 'cardiomyopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214501, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003486', 'abnormal channel response intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214502, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214503, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0013641', 'increased vertebra stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214504, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003996', 'clonic seizures', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214505, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001634', 'internal hemorrhage', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214506, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214507, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008691', 'decreased interleukin-23 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214508, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214509, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003394', 'increased cardiac output', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214510, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214511, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0000427', 'abnormal hair cycle', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214512, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003485', 'abnormal channel response threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214513, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011420', 'pyuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214514, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004009', 'abnormal diastolic filling velocity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214515, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011937', 'shortened PP interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214516, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0000610', 'cholestasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214517, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0005435', 'hemoperitoneum', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214518, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008942', 'abnormal induced cell death', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214519, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0021082', 'abnormal cerebrospinal fluid amyloid beta 42 isoform level', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214520, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002328', 'abnormal airway resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214521, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001947', 'abnormal mucociliary clearance', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214522, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0014028', 'decreased respiratory epithelial chloride transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214523, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214524, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0030214', 'muscle fasciculation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214525, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003474', 'abnormal summary potential intensity', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214526, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0020218', 'abnormal tear production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214527, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214528, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010516', 'absent Q wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214529, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003465', 'increased single cell response threshold', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214530, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011295', 'abnormal tubuloglomerular feedback response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214531, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004876', 'decreased mean systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214532, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004228', 'decreased cellular sensitivity to ionizing radiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214533, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002500', 'granulomatous inflammation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214534, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0031117', 'subdural hemorrhage', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214535, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214536, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0020439', 'absent b-wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214537, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003218', 'decreased spike-wave discharge type I', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214538, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004782', 'abnormal surfactant physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214539, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003489', 'increased channel response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214540, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001844', 'autoimmune response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214541, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010519', 'atrioventricular block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214542, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010950', 'abnormal lung hysteresivity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214543, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214544, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0012685', 'abnormal primitive streak elongation', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214545, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214546, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008943', 'increased sensitivity to induced cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214547, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008775', 'abnormal heart ventricle pressure', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214548, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002325', 'abnormal pulmonary diffusing capacity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214549, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214550, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002919', 'enhanced paired-pulse facilitation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214551, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0021027', 'abnormal cerebrospinal fluid amyloid beta 40 isoform level', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214552, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0020848', 'abnormal exocytosis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214553, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214554, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004212', 'abnormal salty taste sensitivity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214555, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.6086956521739131, 7.291997705654976, 2.1068002513514026, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214556, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002887', 'decreased susceptibility to pharmacologically induced seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214557, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0020001', 'decreased response to antigen', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214558, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0014181', 'abnormal respiratory epithelial sodium ion transmembrane transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214559, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001665', 'chronic diarrhea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214560, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0013285', 'abnormal renal filtration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214561, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0005403', 'abnormal nerve conduction', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214562, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0000350', 'abnormal cell proliferation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214563, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001756', 'abnormal urination', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214564, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001985', 'abnormal gustatory system physiology', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214565, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001629', 'abnormal heart rate', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214566, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214567, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0020080', 'increased bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214568, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0009062', 'impaired lectin complement pathway', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214569, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214570, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002064', 'seizures', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214571, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001943', 'abnormal respiration', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214572, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003216', 'absence seizures', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214573, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004014', 'abnormal uterine environment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214574, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214575, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001914', 'hemorrhage', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214576, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0006051', 'brainstem hemorrhage', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214577, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0012555', 'decreased cell death', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214578, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0013644', 'increased vertebra maximal load', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214579, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010513', 'abnormal ventricular activation time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214580, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004945', 'abnormal bone resorption', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214581, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010758', 'increased right ventricle systolic pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214582, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002911', 'abnormal inhibitory postsynaptic potential', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214583, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0013632', 'increased femur maximal load', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214584, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002421', 'abnormal cell-mediated immunity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214585, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010554', 'shortened HV interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214586, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011953', 'prolonged PQ interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214587, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0000950', 'abnormal seizure response to pharmacological agent', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214588, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214589, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0031090', 'ageusia', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214590, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001746', 'abnormal pituitary secretion', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214591, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002635', 'reduced sensorimotor gating', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214592, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004244', 'abnormal miscarriage rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214593, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004072', 'abnormal frontal plane axis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214594, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214595, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003035', 'decreased pulmonary vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214596, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001752', 'abnormal hypothalamus secretion', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214597, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008055', 'increased urine osmolality', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214598, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002826', 'tonic seizures', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214599, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214600, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010512', 'absent PR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214601, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0000505', 'decreased digestive secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214602, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011220', 'increased intestinal calcium absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214603, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003202', 'abnormal neuron apoptosis', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214604, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002998', 'abnormal bone remodeling', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214605, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0013475', 'delayed reproductive senescence', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214606, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003234', 'enhanced NMDA-mediated synaptic currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214607, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214608, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0009275', 'bruising', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214609, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011046', 'abnormal lung tissue damping', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214610, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0020096', 'high mean heart rate adaptation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214611, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214612, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008697', 'decreased interleukin-3 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214613, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0031110', 'meningitis', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214614, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008564', 'increased interferon-beta secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214615, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002472', 'impaired complement alternative pathway', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214616, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002694', 'abnormal pancreas secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214617, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010570', 'prolonged ST segment', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214618, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214619, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011717', 'increased interleukin-8 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214620, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004046', 'abnormal mitosis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214621, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008722', 'abnormal chemokine secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214622, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0009349', 'increased urine pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214623, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008406', 'increased cellular sensitivity to hydrogen peroxide', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214624, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001948', 'vesicoureteral reflux', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214625, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214626, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214627, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214628, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003633', 'abnormal nervous system physiology', 0.6363636363636364, 7.291997705654976, 2.154149989282523, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214629, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214630, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0000249', 'abnormal blood vessel physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214631, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0013971', 'blood in lymph vessels', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214632, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003741', 'tinnitus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214633, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0009142', 'decreased prepulse inhibition', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214634, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002409', 'decreased susceptibility to infection', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214635, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214636, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008681', 'increased interleukin-17 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214637, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011466', 'increased urine urea nitrogen level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214638, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001927', 'abnormal estrous cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214639, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0021084', 'decreased cerebrospinal fluid amyloid beta 42 isoform level', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214640, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011194', 'abnormal hair follicle physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214641, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010149', 'abnormal synaptic dopamine release', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214642, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002499', 'chronic inflammation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214643, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0005623', 'abnormal meninges morphology', 0.4230769230769231, 4.0017449178869, 1.3011709829220386, 'UPHENO:0004523', 'abnormal nervous system'),
(214644, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0031222', 'decreased CXCL10 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214645, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0005088', 'increased acute inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214646, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003762', 'abnormal immune organ physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214647, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0005551', 'abnormal eye electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214648, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0031424', 'enhanced female fertility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214649, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0006058', 'decreased cerebral infarct size', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214650, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0030951', 'abnormal endocytosis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214651, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214652, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001900', 'impaired synaptic plasticity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214653, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004144', 'hypotonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214654, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002885', 'abnormal AMPA-mediated synaptic currents', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214655, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003566', 'abnormal cell adhesion', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214656, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214657, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004751', 'increased length of allograft survival', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214658, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214659, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008568', 'abnormal interleukin secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214660, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0005005', 'abnormal self tolerance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214661, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214662, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214663, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214664, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214665, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0000243', 'myoclonus', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214666, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011269', 'increased excitatory postsynaptic current amplitude', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214667, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0014256', 'decreased paired-pulse inhibition', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214668, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010746', 'abnormal pre-Botzinger complex physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214669, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0014275', 'increased respiration', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214670, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0014041', 'increased cellular sensitivity to cisplatin', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214671, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214672, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011044', 'increased lung elastance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214673, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0013559', 'abnormal exocrine gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214674, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001633', 'poor circulation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214675, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004416', 'absent cochlear nerve compound action potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214676, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004879', 'decreased systemic vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214677, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0009358', 'environmentally induced seizures', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214678, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003444', 'abnormal neurotransmitter uptake', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214679, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003217', 'increased spike-wave discharge type I', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214680, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0014255', 'increased paired-pulse inhibition', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214681, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0031109', 'subarachnoid hemorrhage', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214682, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0031333', 'decreased inhibitory postsynaptic current amplitude', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214683, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214684, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0012011', 'febrile seizures', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214685, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0014253', 'decreased paired-pulse ratio', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214686, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008271', 'abnormal bone ossification', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214687, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003475', 'increased summary potential intensity', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214688, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011809', 'abnormal anoikis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214689, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.6086956521739131, 7.291997705654976, 2.1068002513514026, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214690, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002907', 'abnormal parturition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214691, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001533', 'abnormal skeleton physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214692, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0013806', 'encephalopathy', 0.6086956521739131, 7.291997705654976, 2.1068002513514026, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214693, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002330', 'abnormal bronchial provocation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214694, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008008', 'early cellular replicative senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214695, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0031014', 'polyspermy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214696, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008685', 'decreased interleukin-18 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214697, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0020097', 'low mean heart rate adaptation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214698, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214699, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0031469', 'abnormal pinocytosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214700, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002886', 'abnormal glutamate-mediated receptor currents', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214701, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0013638', 'decreased femur stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214702, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008921', 'increased neurotransmitter release', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214703, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011432', 'decreased urine flow rate', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214704, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214705, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008562', 'increased interferon-alpha secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214706, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0005445', 'abnormal neurotransmitter secretion', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214707, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008676', 'decreased interleukin-15 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214708, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0020138', 'delayed bone mineralization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214709, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011918', 'abnormal PQ interval', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214710, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214711, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0009247', 'meteorism', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214712, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0009045', 'muscle tetany', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214713, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214714, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002723', 'abnormal immune serum protein physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214715, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0012046', 'decreased susceptibility to hypertension', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214716, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0006045', 'mitral valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214717, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002910', 'abnormal excitatory postsynaptic currents', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214718, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0030904', 'abnormal melanoblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214719, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002879', 'increased cellular sensitivity to X-ray irradiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214720, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004743', 'abnormal vestibular evoked myogenic potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214721, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002296', 'aspiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214722, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214723, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011421', 'cylindruria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214724, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0001475', 'reduced long-term depression', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214725, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0006052', 'cerebellum hemorrhage', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214726, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214727, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003698', 'abnormal male reproductive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214728, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0005085', 'abnormal gallbladder physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214729, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002406', 'increased susceptibility to infection', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214730, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011919', 'abnormal R wave', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214731, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0006082', 'CNS inflammation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214732, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0005446', 'abnormal synaptic epinephrine release', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214733, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003820', 'increased left ventricle systolic pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214734, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004780', 'abnormal surfactant secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214735, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003476', 'decreased summary potential intensity', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214736, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003726', 'decreased autoantibody level', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214737, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0031423', 'abnormal luteolysis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214738, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011938', 'prolonged PP interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214739, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0012033', 'abnormal ERG implicit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214740, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0013642', 'decreased vertebra stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214741, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214742, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004156', 'abnormal QT variability', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214743, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0031129', 'left-to-right shunt', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214744, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003488', 'decreased channel response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214745, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002693', 'abnormal pancreas physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214746, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004766', 'decreased susceptibility to age-related hearing loss', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214747, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003011', 'delayed dark adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214748, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0031170', 'abnormal vasculature physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214749, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0031009', 'abnormal sperm-egg fusion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214750, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008673', 'decreased interleukin-13 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214751, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214752, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214753, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0002896', 'abnormal bone mineralization', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214754, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214755, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0008995', 'early reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214756, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004753', 'abnormal miniature excitatory postsynaptic currents', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214757, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004213', 'abnormal umami taste sensitivity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214758, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0020846', 'abnormal cell motility', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214759, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010946', 'hyperpnea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214760, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214761, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004142', 'abnormal muscle tone', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214762, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214763, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0005253', 'abnormal eye physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214764, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0003477', 'abnormal nerve fiber response', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214765, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0011267', 'abnormal excitatory postsynaptic current amplitude', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(214766, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0031102', 'rhinorrhea', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214767, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004122', 'abnormal sinus arrhythmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214768, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004145', 'abnormal muscle electrophysiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214769, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0031128', 'cardiovascular shunt', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214770, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214771, 'HP:0025699', 'Perisylvian FDG hypermetabolism', 'MP:0010634', 'increased QRS amplitude', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214772, 'HP:0030450', 'Neoplasm of the autonomic nervous system', 'MP:0013915', 'abnormal brachial plexus formation', 0.4375, 7.61846258113911, 1.8256717610918893, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(214773, 'HP:0030450', 'Neoplasm of the autonomic nervous system', 'MP:0001033', 'abnormal parasympathetic system morphology', 0.42424242424242425, 7.61846258113911, 1.7977972728933185, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(214774, 'HP:0030450', 'Neoplasm of the autonomic nervous system', 'MP:0014062', 'nervous system inclusion bodies', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(214775, 'HP:0030450', 'Neoplasm of the autonomic nervous system', 'MP:0002751', 'abnormal autonomic nervous system morphology', 0.45161290322580644, 7.61846258113911, 1.8548843641546513, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(214776, 'HP:0030450', 'Neoplasm of the autonomic nervous system', 'MP:0008311', 'abnormal parasympathetic preganglionic fiber morphology', 0.4117647058823529, 7.61846258113911, 1.7711617667504165, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(214777, 'HP:0030450', 'Neoplasm of the autonomic nervous system', 'MP:0001044', 'abnormal enteric nervous system morphology', 0.42424242424242425, 7.61846258113911, 1.7977972728933185, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(214778, 'HP:0030450', 'Neoplasm of the autonomic nervous system', 'MP:0000959', 'abnormal somatic sensory system morphology', 0.42424242424242425, 7.61846258113911, 1.7977972728933185, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(214779, 'HP:0030450', 'Neoplasm of the autonomic nervous system', 'MP:0001051', 'abnormal somatic motor system morphology', 0.42424242424242425, 7.61846258113911, 1.7977972728933185, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(214780, 'HP:0030450', 'Neoplasm of the autonomic nervous system', 'MP:0002752', 'abnormal somatic nervous system morphology', 0.45161290322580644, 7.61846258113911, 1.8548843641546513, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(214781, 'HP:0030450', 'Neoplasm of the autonomic nervous system', 'MP:0001007', 'abnormal sympathetic system morphology', 0.42424242424242425, 7.61846258113911, 1.7977972728933185, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(214782, 'HP:0030450', 'Neoplasm of the autonomic nervous system', 'MP:0001077', 'abnormal spinal nerve morphology', 0.4117647058823529, 7.61846258113911, 1.7711617667504165, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(214783, 'HP:0030450', 'Neoplasm of the autonomic nervous system', 'MP:0003632', 'abnormal nervous system morphology', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(214784, 'HP:0030450', 'Neoplasm of the autonomic nervous system', 'MP:0008312', 'abnormal sympathetic postganglionic fiber morphology', 0.4117647058823529, 7.61846258113911, 1.7711617667504165, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(214785, 'HP:0030450', 'Neoplasm of the autonomic nervous system', 'MP:0003861', 'abnormal nervous system development', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(214786, 'HP:0030450', 'Neoplasm of the autonomic nervous system', 'MP:0012260', 'encephalomeningocele', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(214787, 'HP:0030450', 'Neoplasm of the autonomic nervous system', 'MP:0008310', 'abnormal sympathetic preganglionic fiber morphology', 0.4117647058823529, 7.61846258113911, 1.7711617667504165, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(214788, 'HP:0030450', 'Neoplasm of the autonomic nervous system', 'MP:0008313', 'abnormal parasympathetic postganglionic fiber morphology', 0.4117647058823529, 7.61846258113911, 1.7711617667504165, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(214789, 'HP:0032593', 'Myoglobin casts', 'MP:0004050', 'abnormal renal sympathetic nerve activity', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214790, 'HP:0032593', 'Myoglobin casts', 'MP:0001756', 'abnormal urination', 0.4666666666666667, 8.666588959537362, 2.011071401297685, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214791, 'HP:0032593', 'Myoglobin casts', 'MP:0010107', 'abnormal renal reabsorption', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214792, 'HP:0032593', 'Myoglobin casts', 'MP:0014037', 'stranguria', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214793, 'HP:0032593', 'Myoglobin casts', 'MP:0011420', 'pyuria', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214794, 'HP:0032593', 'Myoglobin casts', 'MP:0031483', 'decreased urine hypoxanthine level', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214795, 'HP:0032593', 'Myoglobin casts', 'MP:0011444', 'abnormal renal water homeostasis', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214796, 'HP:0032593', 'Myoglobin casts', 'MP:0030619', 'homogentisic aciduria', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214797, 'HP:0032593', 'Myoglobin casts', 'MP:0002893', 'ketoaciduria', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214798, 'HP:0032593', 'Myoglobin casts', 'MP:0031480', 'abnormal urine xanthine level', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214799, 'HP:0032593', 'Myoglobin casts', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.4827586206896552, 8.666588959537362, 2.045451180593282, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214800, 'HP:0032593', 'Myoglobin casts', 'MP:0011467', 'decreased urine urea nitrogen level', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214801, 'HP:0032593', 'Myoglobin casts', 'MP:0001761', 'abnormal urination pattern', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214802, 'HP:0032593', 'Myoglobin casts', 'MP:0031481', 'decreased urine xanthine level', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214803, 'HP:0032593', 'Myoglobin casts', 'MP:0011417', 'abnormal renal transport', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214804, 'HP:0032593', 'Myoglobin casts', 'MP:0013305', 'isosthenuria', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214805, 'HP:0032593', 'Myoglobin casts', 'MP:0011431', 'increased urine flow rate', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214806, 'HP:0032593', 'Myoglobin casts', 'MP:0003280', 'urinary incontinence', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214807, 'HP:0032593', 'Myoglobin casts', 'MP:0003621', 'dysuria', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214808, 'HP:0032593', 'Myoglobin casts', 'MP:0009645', 'crystalluria', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214809, 'HP:0032593', 'Myoglobin casts', 'MP:0011465', 'abnormal urine urea nitrogen level', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214810, 'HP:0032593', 'Myoglobin casts', 'MP:0031482', 'abnormal urine hypoxanthine level', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214811, 'HP:0032593', 'Myoglobin casts', 'MP:0011295', 'abnormal tubuloglomerular feedback response', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214812, 'HP:0032593', 'Myoglobin casts', 'MP:0011923', 'abnormal bladder urine volume', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214813, 'HP:0032593', 'Myoglobin casts', 'MP:0011421', 'cylindruria', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214814, 'HP:0032593', 'Myoglobin casts', 'MP:0013285', 'abnormal renal filtration', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214815, 'HP:0032593', 'Myoglobin casts', 'MP:0001948', 'vesicoureteral reflux', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214816, 'HP:0032593', 'Myoglobin casts', 'MP:0010028', 'aciduria', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214817, 'HP:0032593', 'Myoglobin casts', 'MP:0002988', 'decreased urine osmolality', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214818, 'HP:0032593', 'Myoglobin casts', 'MP:0002987', 'abnormal urine osmolality', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214819, 'HP:0032593', 'Myoglobin casts', 'MP:0031479', 'increased urine xanthine level', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214820, 'HP:0032593', 'Myoglobin casts', 'MP:0009643', 'abnormal urine homeostasis', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214821, 'HP:0032593', 'Myoglobin casts', 'MP:0008055', 'increased urine osmolality', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214822, 'HP:0032593', 'Myoglobin casts', 'MP:0009349', 'increased urine pH', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214823, 'HP:0032593', 'Myoglobin casts', 'MP:0003589', 'abnormal ureter physiology', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214824, 'HP:0032593', 'Myoglobin casts', 'MP:0011758', 'renal ischemia', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214825, 'HP:0032593', 'Myoglobin casts', 'MP:0010386', 'abnormal urinary bladder physiology', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214826, 'HP:0032593', 'Myoglobin casts', 'MP:0002136', 'abnormal kidney physiology', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214827, 'HP:0032593', 'Myoglobin casts', 'MP:0009348', 'abnormal urine pH', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214828, 'HP:0032593', 'Myoglobin casts', 'MP:0011466', 'increased urine urea nitrogen level', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214829, 'HP:0032593', 'Myoglobin casts', 'MP:0011418', 'leukocyturia', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214830, 'HP:0032593', 'Myoglobin casts', 'MP:0009350', 'decreased urine pH', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214831, 'HP:0032593', 'Myoglobin casts', 'MP:0000327', 'hemosiderinuria', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214832, 'HP:0032593', 'Myoglobin casts', 'MP:0006273', 'abnormal urine organic cation level', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214833, 'HP:0032593', 'Myoglobin casts', 'MP:0011900', 'podocyturia', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214834, 'HP:0032593', 'Myoglobin casts', 'MP:0031484', 'increased urine hypoxanthine level', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214835, 'HP:0032593', 'Myoglobin casts', 'MP:0011432', 'decreased urine flow rate', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214836, 'HP:0012309', 'Cutaneous amyloidosis', 'MP:0000001', 'mammalian phenotype', 0.42857142857142855, 1.5524157786304194, 0.8156721449114622, 'UPHENO:0001003', 'phenotype by ontology source'),
(214837, 'HP:0012309', 'Cutaneous amyloidosis', 'MP:0005332', 'abnormal amino acid level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(214838, 'HP:0012309', 'Cutaneous amyloidosis', 'MP:0005499', 'abnormal olfactory system morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(214839, 'HP:0012309', 'Cutaneous amyloidosis', 'MP:0021122', 'abnormal trimethylamine N-oxide level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(214840, 'HP:0012309', 'Cutaneous amyloidosis', 'MP:0011479', 'abnormal catecholamine level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(214841, 'HP:0012309', 'Cutaneous amyloidosis', 'MP:0005500', 'abnormal gustatory system morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(214842, 'HP:0012309', 'Cutaneous amyloidosis', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(214843, 'HP:0012309', 'Cutaneous amyloidosis', 'MP:0002111', 'abnormal tail morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(214844, 'HP:0012309', 'Cutaneous amyloidosis', 'MP:0002163', 'abnormal gland morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(214845, 'HP:0012309', 'Cutaneous amyloidosis', 'MP:0011989', 'abnormal porphyrin level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(214846, 'HP:0012309', 'Cutaneous amyloidosis', 'MP:0011475', 'abnormal glycosaminoglycan level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(214847, 'HP:0012309', 'Cutaneous amyloidosis', 'MP:0003385', 'abnormal body wall morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(214848, 'HP:0012309', 'Cutaneous amyloidosis', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(214849, 'HP:0012309', 'Cutaneous amyloidosis', 'MP:0010678', 'abnormal skin adnexa morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(214850, 'HP:0012309', 'Cutaneous amyloidosis', 'MP:0008469', 'abnormal protein level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(214851, 'HP:0012309', 'Cutaneous amyloidosis', 'MP:0014134', 'abnormal embryo morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(214852, 'HP:0012309', 'Cutaneous amyloidosis', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(214853, 'HP:0012309', 'Cutaneous amyloidosis', 'MP:0021145', 'abnormal amino acid derivative level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(214854, 'HP:0033011', 'Platystencephaly', 'MP:0010031', 'abnormal cranium size', 0.42857142857142855, 7.173214147510782, 1.7533495471945912, 'UPHENO:0081566', 'abnormal skull morphology'),
(214855, 'HP:0033011', 'Platystencephaly', 'MP:0000919', 'cranioschisis', 0.42, 7.173214147510782, 1.7357274964563212, 'UPHENO:0081566', 'abnormal skull morphology'),
(214856, 'HP:0033011', 'Platystencephaly', 'MP:0011496', 'abnormal head size', 0.40476190476190477, 4.6730878730104815, 1.3753137636915733, 'UPHENO:0087907', 'abnormal head morphology'),
(214857, 'HP:0001551', 'Abnormal umbilicus morphology', 'MP:0000474', 'abnormal foregut morphology', 0.4074074074074074, 5.110459900932426, 1.4429273089447008, 'UPHENO:0002833', 'abnormal digestive system'),
(214858, 'HP:0001551', 'Abnormal umbilicus morphology', 'MP:0002111', 'abnormal tail morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(214859, 'HP:0001551', 'Abnormal umbilicus morphology', 'MP:0010352', 'gastrointestinal tract polyps', 0.44, 5.110459900932426, 1.4995340464325135, 'UPHENO:0002833', 'abnormal digestive system'),
(214860, 'HP:0001551', 'Abnormal umbilicus morphology', 'MP:0002163', 'abnormal gland morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(214861, 'HP:0001551', 'Abnormal umbilicus morphology', 'MP:0003300', 'gastrointestinal ulcer', 0.44, 5.110459900932426, 1.4995340464325135, 'UPHENO:0002833', 'abnormal digestive system'),
(214862, 'HP:0001551', 'Abnormal umbilicus morphology', 'MP:0004547', 'esophageal ulcer', 0.4074074074074074, 5.110459900932426, 1.4429273089447008, 'UPHENO:0002833', 'abnormal digestive system'),
(214863, 'HP:0001551', 'Abnormal umbilicus morphology', 'MP:0009705', 'abnormal midgut morphology', 0.4074074074074074, 5.110459900932426, 1.4429273089447008, 'UPHENO:0002833', 'abnormal digestive system'),
(214864, 'HP:0001551', 'Abnormal umbilicus morphology', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(214865, 'HP:0001551', 'Abnormal umbilicus morphology', 'MP:0014134', 'abnormal embryo morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(214866, 'HP:0001551', 'Abnormal umbilicus morphology', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(214867, 'HP:0001551', 'Abnormal umbilicus morphology', 'MP:0005500', 'abnormal gustatory system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(214868, 'HP:0001551', 'Abnormal umbilicus morphology', 'MP:0000462', 'abnormal digestive system morphology', 0.4583333333333333, 5.110459900932426, 1.5304555273710816, 'UPHENO:0002833', 'abnormal digestive system'),
(214869, 'HP:0001551', 'Abnormal umbilicus morphology', 'MP:0000467', 'abnormal esophagus morphology', 0.4230769230769231, 5.110459900932426, 1.4704141084723337, 'UPHENO:0002833', 'abnormal digestive system'),
(214870, 'HP:0001551', 'Abnormal umbilicus morphology', 'MP:0008786', 'abnormal hindgut morphology', 0.4074074074074074, 5.110459900932426, 1.4429273089447008, 'UPHENO:0002833', 'abnormal digestive system'),
(214871, 'HP:0001551', 'Abnormal umbilicus morphology', 'MP:0010678', 'abnormal skin adnexa morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(214872, 'HP:0001551', 'Abnormal umbilicus morphology', 'MP:0003385', 'abnormal body wall morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(214873, 'HP:0001551', 'Abnormal umbilicus morphology', 'MP:0005499', 'abnormal olfactory system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(214874, 'HP:0001551', 'Abnormal umbilicus morphology', 'MP:0003257', 'abnormal abdominal wall morphology', 0.4074074074074074, 10.982656403003482, 2.1152814402802314, 'UPHENO:0075843', 'abnormal abdominal wall'),
(214875, 'HP:0001551', 'Abnormal umbilicus morphology', 'MP:0003119', 'abnormal digestive system development', 0.44, 5.110459900932426, 1.4995340464325135, 'UPHENO:0002833', 'abnormal digestive system'),
(214876, 'HP:0001551', 'Abnormal umbilicus morphology', 'MP:0002138', 'abnormal hepatobiliary system morphology', 0.4074074074074074, 5.110459900932426, 1.4429273089447008, 'UPHENO:0002833', 'abnormal digestive system'),
(214877, 'HP:0001551', 'Abnormal umbilicus morphology', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(214878, 'HP:0001551', 'Abnormal umbilicus morphology', 'MP:0003301', 'peptic ulcer', 0.4230769230769231, 5.110459900932426, 1.4704141084723337, 'UPHENO:0002833', 'abnormal digestive system'),
(214879, 'HP:0001551', 'Abnormal umbilicus morphology', 'MP:0003673', 'abnormal inguinal canal morphology', 0.4074074074074074, 10.982656403003482, 2.1152814402802314, 'UPHENO:0075843', 'abnormal abdominal wall'),
(214880, 'HP:0008857', 'Neonatal short-trunk short stature', 'MP:0001255', 'decreased body height', 0.4074074074074074, 13.384754846574829, 2.3351762826019757, 'UPHENO:0080352', 'decreased height of the multicellular organism'),
(214881, 'HP:0007190', 'Neuronal loss in the cerebral cortex', 'MP:0008948', 'decreased neuron number', 0.43548387096774194, 12.104646927382092, 2.2959482791722765, 'UPHENO:0088342', 'abnormally decreased number of neuron in the independent continuant'),
(214882, 'HP:0007190', 'Neuronal loss in the cerebral cortex', 'MP:0009975', 'absent cerebral cortex pyramidal cells', 0.44047619047619047, 15.192109768632433, 2.5868441460944904, 'UPHENO:0088330', 'abnormally decreased number of neuron in the cerebral cortex'),
(214883, 'HP:0007190', 'Neuronal loss in the cerebral cortex', 'MP:0009974', 'decreased cerebral cortex pyramidal cell number', 0.5211267605633803, 15.192109768632433, 2.8137190602209565, 'UPHENO:0088330', 'abnormally decreased number of neuron in the cerebral cortex'),
(214884, 'HP:0007190', 'Neuronal loss in the cerebral cortex', 'MP:0009971', 'decreased hippocampus pyramidal cell number', 0.4111111111111111, 15.192109768632433, 2.4991288736486648, 'UPHENO:0088330', 'abnormally decreased number of neuron in the cerebral cortex'),
(214885, 'HP:0007190', 'Neuronal loss in the cerebral cortex', 'MP:0008031', 'decreased Cajal-Retzius cell number', 0.44, 13.237913458245556, 2.4134377807658614, 'UPHENO:0088328', 'abnormally decreased number of neuron in the central nervous system'),
(214886, 'HP:0007190', 'Neuronal loss in the cerebral cortex', 'MP:0011448', 'decreased dopaminergic neuron number', 0.4090909090909091, 12.104646927382092, 2.225286726637091, 'UPHENO:0088342', 'abnormally decreased number of neuron in the independent continuant'),
(214887, 'HP:0011755', 'Ectopic posterior pituitary', 'MP:0013358', 'ectopic neurohypophysis', 0.463768115942029, 16.607147267911277, 2.775223486426098, 'UPHENO:0053586', 'abnormally localised neurohypophysis'),
(214888, 'HP:0011755', 'Ectopic posterior pituitary', 'MP:0013356', 'ectopic pituitary gland', 0.417910447761194, 10.291242960651683, 2.0738413521060814, 'UPHENO:0087940', 'abnormal pituitary gland morphology'),
(214889, 'HP:0033359', 'Hyperosthenuria', 'MP:0011297', 'absent tubuloglomerular feedback response', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214890, 'HP:0033359', 'Hyperosthenuria', 'MP:0002133', 'abnormal respiratory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214891, 'HP:0033359', 'Hyperosthenuria', 'MP:0004558', 'delayed allantois development', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214892, 'HP:0033359', 'Hyperosthenuria', 'MP:0009645', 'crystalluria', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214893, 'HP:0033359', 'Hyperosthenuria', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214894, 'HP:0033359', 'Hyperosthenuria', 'MP:0003606', 'kidney failure', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214895, 'HP:0033359', 'Hyperosthenuria', 'MP:0009350', 'decreased urine pH', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214896, 'HP:0033359', 'Hyperosthenuria', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.5185185185185185, 8.666588959537362, 2.119855388442396, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214897, 'HP:0033359', 'Hyperosthenuria', 'MP:0012685', 'abnormal primitive streak elongation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214898, 'HP:0033359', 'Hyperosthenuria', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214899, 'HP:0033359', 'Hyperosthenuria', 'MP:0001760', 'abnormal urine enzyme level', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214900, 'HP:0033359', 'Hyperosthenuria', 'MP:0031483', 'decreased urine hypoxanthine level', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214901, 'HP:0033359', 'Hyperosthenuria', 'MP:0031479', 'increased urine xanthine level', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214902, 'HP:0033359', 'Hyperosthenuria', 'MP:0009643', 'abnormal urine homeostasis', 0.4666666666666667, 8.666588959537362, 2.011071401297685, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214903, 'HP:0033359', 'Hyperosthenuria', 'MP:0010386', 'abnormal urinary bladder physiology', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214904, 'HP:0033359', 'Hyperosthenuria', 'MP:0031484', 'increased urine hypoxanthine level', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214905, 'HP:0033359', 'Hyperosthenuria', 'MP:0002164', 'abnormal gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214906, 'HP:0033359', 'Hyperosthenuria', 'MP:0011856', 'abnormal glomerular filtration barrier function', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214907, 'HP:0033359', 'Hyperosthenuria', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214908, 'HP:0033359', 'Hyperosthenuria', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214909, 'HP:0033359', 'Hyperosthenuria', 'MP:0013284', 'abnormal renal glomerular filtration', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214910, 'HP:0033359', 'Hyperosthenuria', 'MP:0003633', 'abnormal nervous system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214911, 'HP:0033359', 'Hyperosthenuria', 'MP:0003589', 'abnormal ureter physiology', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214912, 'HP:0033359', 'Hyperosthenuria', 'MP:0011758', 'renal ischemia', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214913, 'HP:0033359', 'Hyperosthenuria', 'MP:0002987', 'abnormal urine osmolality', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214914, 'HP:0033359', 'Hyperosthenuria', 'MP:0006273', 'abnormal urine organic cation level', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214915, 'HP:0033359', 'Hyperosthenuria', 'MP:0011431', 'increased urine flow rate', 0.4827586206896552, 8.666588959537362, 2.045451180593282, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214916, 'HP:0033359', 'Hyperosthenuria', 'MP:0013285', 'abnormal renal filtration', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214917, 'HP:0033359', 'Hyperosthenuria', 'MP:0004051', 'increased renal sympathetic nerve activity', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214918, 'HP:0033359', 'Hyperosthenuria', 'MP:0011421', 'cylindruria', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214919, 'HP:0033359', 'Hyperosthenuria', 'MP:0001919', 'abnormal reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214920, 'HP:0033359', 'Hyperosthenuria', 'MP:0011442', 'abnormal renal sodium ion transport', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214921, 'HP:0033359', 'Hyperosthenuria', 'MP:0004040', 'abnormal susceptibility to kidney reperfusion injury', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214922, 'HP:0033359', 'Hyperosthenuria', 'MP:0003280', 'urinary incontinence', 0.4827586206896552, 8.666588959537362, 2.045451180593282, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214923, 'HP:0033359', 'Hyperosthenuria', 'MP:0030619', 'homogentisic aciduria', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214924, 'HP:0033359', 'Hyperosthenuria', 'MP:0010028', 'aciduria', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214925, 'HP:0033359', 'Hyperosthenuria', 'MP:0011444', 'abnormal renal water homeostasis', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214926, 'HP:0033359', 'Hyperosthenuria', 'MP:0011900', 'podocyturia', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214927, 'HP:0033359', 'Hyperosthenuria', 'MP:0001663', 'abnormal digestive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214928, 'HP:0033359', 'Hyperosthenuria', 'MP:0009348', 'abnormal urine pH', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214929, 'HP:0033359', 'Hyperosthenuria', 'MP:0001790', 'abnormal immune system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214930, 'HP:0033359', 'Hyperosthenuria', 'MP:0011295', 'abnormal tubuloglomerular feedback response', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214931, 'HP:0033359', 'Hyperosthenuria', 'MP:0010107', 'abnormal renal reabsorption', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214932, 'HP:0033359', 'Hyperosthenuria', 'MP:0011466', 'increased urine urea nitrogen level', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214933, 'HP:0033359', 'Hyperosthenuria', 'MP:0002136', 'abnormal kidney physiology', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214934, 'HP:0033359', 'Hyperosthenuria', 'MP:0001986', 'abnormal taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214935, 'HP:0033359', 'Hyperosthenuria', 'MP:0005666', 'abnormal adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214936, 'HP:0033359', 'Hyperosthenuria', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214937, 'HP:0033359', 'Hyperosthenuria', 'MP:0031481', 'decreased urine xanthine level', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214938, 'HP:0033359', 'Hyperosthenuria', 'MP:0013305', 'isosthenuria', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214939, 'HP:0033359', 'Hyperosthenuria', 'MP:0011418', 'leukocyturia', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214940, 'HP:0033359', 'Hyperosthenuria', 'MP:0011465', 'abnormal urine urea nitrogen level', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214941, 'HP:0033359', 'Hyperosthenuria', 'MP:0005621', 'abnormal cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214942, 'HP:0033359', 'Hyperosthenuria', 'MP:0001761', 'abnormal urination pattern', 0.4827586206896552, 8.666588959537362, 2.045451180593282, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214943, 'HP:0033359', 'Hyperosthenuria', 'MP:0008055', 'increased urine osmolality', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214944, 'HP:0033359', 'Hyperosthenuria', 'MP:0010680', 'abnormal skin adnexa physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214945, 'HP:0033359', 'Hyperosthenuria', 'MP:0009349', 'increased urine pH', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214946, 'HP:0033359', 'Hyperosthenuria', 'MP:0001985', 'abnormal gustatory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214947, 'HP:0033359', 'Hyperosthenuria', 'MP:0031482', 'abnormal urine hypoxanthine level', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214948, 'HP:0033359', 'Hyperosthenuria', 'MP:0001984', 'abnormal olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214949, 'HP:0033359', 'Hyperosthenuria', 'MP:0004050', 'abnormal renal sympathetic nerve activity', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214950, 'HP:0033359', 'Hyperosthenuria', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214951, 'HP:0033359', 'Hyperosthenuria', 'MP:0000427', 'abnormal hair cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214952, 'HP:0033359', 'Hyperosthenuria', 'MP:0000327', 'hemosiderinuria', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214953, 'HP:0033359', 'Hyperosthenuria', 'MP:0003621', 'dysuria', 0.4827586206896552, 8.666588959537362, 2.045451180593282, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214954, 'HP:0033359', 'Hyperosthenuria', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214955, 'HP:0033359', 'Hyperosthenuria', 'MP:0002988', 'decreased urine osmolality', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214956, 'HP:0033359', 'Hyperosthenuria', 'MP:0011296', 'decreased tubuloglomerular feedback response', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214957, 'HP:0033359', 'Hyperosthenuria', 'MP:0002893', 'ketoaciduria', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214958, 'HP:0033359', 'Hyperosthenuria', 'MP:0011417', 'abnormal renal transport', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214959, 'HP:0033359', 'Hyperosthenuria', 'MP:0011467', 'decreased urine urea nitrogen level', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214960, 'HP:0033359', 'Hyperosthenuria', 'MP:0004052', 'decreased renal sympathetic nerve activity', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214961, 'HP:0033359', 'Hyperosthenuria', 'MP:0011762', 'renal/urinary system inflammation', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214962, 'HP:0033359', 'Hyperosthenuria', 'MP:0011923', 'abnormal bladder urine volume', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214963, 'HP:0033359', 'Hyperosthenuria', 'MP:0031404', 'increased tubuloglomerular feedback response', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214964, 'HP:0033359', 'Hyperosthenuria', 'MP:0001533', 'abnormal skeleton physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214965, 'HP:0033359', 'Hyperosthenuria', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214966, 'HP:0033359', 'Hyperosthenuria', 'MP:0014037', 'stranguria', 0.4827586206896552, 8.666588959537362, 2.045451180593282, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214967, 'HP:0033359', 'Hyperosthenuria', 'MP:0001948', 'vesicoureteral reflux', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214968, 'HP:0033359', 'Hyperosthenuria', 'MP:0002106', 'abnormal muscle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214969, 'HP:0033359', 'Hyperosthenuria', 'MP:0011432', 'decreased urine flow rate', 0.4827586206896552, 8.666588959537362, 2.045451180593282, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214970, 'HP:0033359', 'Hyperosthenuria', 'MP:0011443', 'abnormal renal water transport', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214971, 'HP:0033359', 'Hyperosthenuria', 'MP:0001983', 'abnormal olfactory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214972, 'HP:0033359', 'Hyperosthenuria', 'MP:0011420', 'pyuria', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214973, 'HP:0033359', 'Hyperosthenuria', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214974, 'HP:0033359', 'Hyperosthenuria', 'MP:0001756', 'abnormal urination', 0.5, 8.666588959537362, 2.081656667120849, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214975, 'HP:0033359', 'Hyperosthenuria', 'MP:0031480', 'abnormal urine xanthine level', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(214976, 'HP:0033359', 'Hyperosthenuria', 'MP:0031092', 'dysgeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214977, 'HP:0000011', 'Neurogenic bladder', 'MP:0010386', 'abnormal urinary bladder physiology', 0.5333333333333333, 13.062826751687464, 2.6394773979394697, 'UPHENO:0002437', 'abnormality of urinary bladder physiology'),
(214978, 'HP:0000011', 'Neurogenic bladder', 'MP:0010680', 'abnormal skin adnexa physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214979, 'HP:0000011', 'Neurogenic bladder', 'MP:0009646', 'urinary bladder inflammation', 0.42105263157894735, 13.062826751687464, 2.345237211809901, 'UPHENO:0002437', 'abnormality of urinary bladder physiology'),
(214980, 'HP:0000011', 'Neurogenic bladder', 'MP:0011431', 'increased urine flow rate', 0.41935483870967744, 6.416088053379619, 1.6403102056538266, 'UPHENO:0002832', 'abnormal renal system'),
(214981, 'HP:0000011', 'Neurogenic bladder', 'MP:0002164', 'abnormal gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214982, 'HP:0000011', 'Neurogenic bladder', 'MP:0001985', 'abnormal gustatory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214983, 'HP:0000011', 'Neurogenic bladder', 'MP:0014037', 'stranguria', 0.41935483870967744, 6.416088053379619, 1.6403102056538266, 'UPHENO:0002832', 'abnormal renal system'),
(214984, 'HP:0000011', 'Neurogenic bladder', 'MP:0005302', 'neurogenic bladder', 0.42105263157894735, 13.062826751687464, 2.345237211809901, 'UPHENO:0002437', 'abnormality of urinary bladder physiology'),
(214985, 'HP:0000011', 'Neurogenic bladder', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214986, 'HP:0000011', 'Neurogenic bladder', 'MP:0009643', 'abnormal urine homeostasis', 0.40625, 6.416088053379619, 1.6144769343925203, 'UPHENO:0002832', 'abnormal renal system'),
(214987, 'HP:0000011', 'Neurogenic bladder', 'MP:0001761', 'abnormal urination pattern', 0.41935483870967744, 6.416088053379619, 1.6403102056538266, 'UPHENO:0002832', 'abnormal renal system'),
(214988, 'HP:0000011', 'Neurogenic bladder', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214989, 'HP:0000011', 'Neurogenic bladder', 'MP:0001756', 'abnormal urination', 0.43333333333333335, 6.416088053379619, 1.6674246079301962, 'UPHENO:0002832', 'abnormal renal system'),
(214990, 'HP:0000011', 'Neurogenic bladder', 'MP:0001983', 'abnormal olfactory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214991, 'HP:0000011', 'Neurogenic bladder', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.4482758620689655, 6.416088053379619, 1.6959296575150573, 'UPHENO:0002832', 'abnormal renal system'),
(214992, 'HP:0000011', 'Neurogenic bladder', 'MP:0003621', 'dysuria', 0.41935483870967744, 6.416088053379619, 1.6403102056538266, 'UPHENO:0002832', 'abnormal renal system'),
(214993, 'HP:0000011', 'Neurogenic bladder', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(214994, 'HP:0000011', 'Neurogenic bladder', 'MP:0011432', 'decreased urine flow rate', 0.41935483870967744, 6.416088053379619, 1.6403102056538266, 'UPHENO:0002832', 'abnormal renal system'),
(214995, 'HP:0000011', 'Neurogenic bladder', 'MP:0003280', 'urinary incontinence', 0.41935483870967744, 6.416088053379619, 1.6403102056538266, 'UPHENO:0002832', 'abnormal renal system'),
(214996, 'HP:0000011', 'Neurogenic bladder', 'MP:0011923', 'abnormal bladder urine volume', 0.5161290322580645, 13.062826751687464, 2.596556205804759, 'UPHENO:0002437', 'abnormality of urinary bladder physiology'),
(214997, 'HP:0003302', 'Spondylolisthesis', 'MP:0004626', 'vertebral compression', 0.40476190476190477, 8.052558416233639, 1.8053722283122766, 'UPHENO:0002813', 'abnormal vertebral column'),
(214998, 'HP:0003302', 'Spondylolisthesis', 'MP:0003956', 'abnormal body size', 0.40625, 3.067140347159989, 1.1162552423320329, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(214999, 'HP:0003302', 'Spondylolisthesis', 'MP:0010113', 'abnormal sacrum morphology', 0.4117647058823529, 8.052558416233639, 1.8209226638879836, 'UPHENO:0002813', 'abnormal vertebral column'),
(215000, 'HP:0003302', 'Spondylolisthesis', 'MP:0009345', 'abnormal trabecular bone thickness', 0.40540540540540543, 4.825104621810128, 1.3986148488159384, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(215001, 'HP:0003302', 'Spondylolisthesis', 'MP:0003200', 'calcified joint', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(215002, 'HP:0003302', 'Spondylolisthesis', 'MP:0010876', 'decreased bone volume', 0.40540540540540543, 4.825104621810128, 1.3986148488159384, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(215003, 'HP:0003302', 'Spondylolisthesis', 'MP:0000071', 'axial skeleton hypoplasia', 0.42105263157894735, 6.976576768886775, 1.7139154027991947, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(215004, 'HP:0003302', 'Spondylolisthesis', 'MP:0000459', 'abnormal presacral vertebrae morphology', 0.4166666666666667, 8.052558416233639, 1.83172942145686, 'UPHENO:0002813', 'abnormal vertebral column'),
(215005, 'HP:0003302', 'Spondylolisthesis', 'MP:0013844', 'abnormal perichondrial ossification', 0.4411764705882353, 4.825104621810128, 1.4590142656153757, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(215006, 'HP:0003302', 'Spondylolisthesis', 'MP:0010104', 'enlarged thoracic cage', 0.42105263157894735, 6.976576768886775, 1.7139154027991947, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(215007, 'HP:0003302', 'Spondylolisthesis', 'MP:0010103', 'small thoracic cage', 0.42105263157894735, 6.976576768886775, 1.7139154027991947, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(215008, 'HP:0003302', 'Spondylolisthesis', 'MP:0006322', 'abnormal perichondrium morphology', 0.45454545454545453, 4.825104621810128, 1.4809555609639535, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(215009, 'HP:0003302', 'Spondylolisthesis', 'MP:0021136', 'abnormal vertebrae shape', 0.425, 8.052558416233639, 1.8499560337746668, 'UPHENO:0002813', 'abnormal vertebral column'),
(215010, 'HP:0003302', 'Spondylolisthesis', 'MP:0004675', 'rib fractures', 0.42105263157894735, 6.976576768886775, 1.7139154027991947, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(215011, 'HP:0003302', 'Spondylolisthesis', 'MP:0004610', 'small vertebrae', 0.4358974358974359, 8.052558416233639, 1.8735233027775664, 'UPHENO:0002813', 'abnormal vertebral column'),
(215012, 'HP:0003302', 'Spondylolisthesis', 'MP:0004669', 'enlarged vertebral body', 0.4146341463414634, 8.052558416233639, 1.8272563270597264, 'UPHENO:0002813', 'abnormal vertebral column'),
(215013, 'HP:0003302', 'Spondylolisthesis', 'MP:0010928', 'abnormal osteoid thickness', 0.40540540540540543, 4.825104621810128, 1.3986148488159384, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(215014, 'HP:0003302', 'Spondylolisthesis', 'MP:0004624', 'abnormal thoracic cage morphology', 0.40625, 6.976576768886775, 1.6835184324385202, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(215015, 'HP:0003302', 'Spondylolisthesis', 'MP:0000137', 'abnormal vertebrae morphology', 0.4117647058823529, 8.052558416233639, 1.8209226638879836, 'UPHENO:0002813', 'abnormal vertebral column'),
(215016, 'HP:0003302', 'Spondylolisthesis', 'MP:0004670', 'small vertebral body', 0.40476190476190477, 8.052558416233639, 1.8053722283122766, 'UPHENO:0002813', 'abnormal vertebral column'),
(215017, 'HP:0003302', 'Spondylolisthesis', 'MP:0021137', 'abnormal wedge-shaped vertebrae', 0.4146341463414634, 8.052558416233639, 1.8272563270597264, 'UPHENO:0002813', 'abnormal vertebral column'),
(215018, 'HP:0003302', 'Spondylolisthesis', 'MP:0004703', 'abnormal vertebral column morphology', 0.4375, 8.052558416233639, 1.8769641198228104, 'UPHENO:0002813', 'abnormal vertebral column'),
(215019, 'HP:0003302', 'Spondylolisthesis', 'MP:0004174', 'abnormal spine curvature', 0.42424242424242425, 8.052558416233639, 1.8483064961896052, 'UPHENO:0002813', 'abnormal vertebral column'),
(215020, 'HP:0003302', 'Spondylolisthesis', 'MP:0000160', 'kyphosis', 0.4117647058823529, 8.052558416233639, 1.8209226638879836, 'UPHENO:0002813', 'abnormal vertebral column'),
(215021, 'HP:0003302', 'Spondylolisthesis', 'MP:0031313', 'spondylolisthesis', 0.42424242424242425, 8.052558416233639, 1.8483064961896052, 'UPHENO:0002813', 'abnormal vertebral column'),
(215022, 'HP:0003302', 'Spondylolisthesis', 'MP:0010099', 'abnormal thoracic cage shape', 0.41025641025641024, 6.976576768886775, 1.691799438787516, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(215023, 'HP:0003302', 'Spondylolisthesis', 'MP:0031312', 'spondylolysis', 0.42424242424242425, 8.052558416233639, 1.8483064961896052, 'UPHENO:0002813', 'abnormal vertebral column'),
(215024, 'HP:0003302', 'Spondylolisthesis', 'MP:0010875', 'increased bone volume', 0.40540540540540543, 4.825104621810128, 1.3986148488159384, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(215025, 'HP:0003302', 'Spondylolisthesis', 'MP:0004986', 'abnormal osteoblast morphology', 0.40540540540540543, 4.825104621810128, 1.3986148488159384, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(215026, 'HP:0003302', 'Spondylolisthesis', 'MP:0008771', 'elongated vertebral column', 0.425, 8.052558416233639, 1.8499560337746668, 'UPHENO:0002813', 'abnormal vertebral column'),
(215027, 'HP:0003302', 'Spondylolisthesis', 'MP:0002114', 'abnormal axial skeleton morphology', 0.43333333333333335, 6.976576768886775, 1.738730360498028, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(215028, 'HP:0003302', 'Spondylolisthesis', 'MP:0004704', 'short vertebral column', 0.425, 8.052558416233639, 1.8499560337746668, 'UPHENO:0002813', 'abnormal vertebral column'),
(215029, 'HP:0003302', 'Spondylolisthesis', 'MP:0000162', 'lordosis', 0.4117647058823529, 8.052558416233639, 1.8209226638879836, 'UPHENO:0002813', 'abnormal vertebral column'),
(215030, 'HP:0003302', 'Spondylolisthesis', 'MP:0005508', 'abnormal skeleton morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(215031, 'HP:0003302', 'Spondylolisthesis', 'MP:0000161', 'scoliosis', 0.4117647058823529, 8.052558416233639, 1.8209226638879836, 'UPHENO:0002813', 'abnormal vertebral column'),
(215032, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0010176', 'dacryocytosis', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(215033, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0010074', 'stomatocytosis', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(215034, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0002596', 'abnormal hematocrit', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(215035, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0012372', 'abnormal erythrocyte ion content', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(215036, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0000358', 'abnormal cell morphology', 0.45161290322580644, 6.121988824155609, 1.6627594974598268, 'UPHENO:0084928', 'abnormal cell morphology'),
(215037, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0004230', 'abnormal embryonic erythrocyte morphology', 0.4090909090909091, 10.15319077934013, 2.03803288641123, 'UPHENO:0088170', 'abnormal erythroid lineage cell morphology'),
(215038, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0013657', 'abnormal blood cell morphology', 0.41025641025641024, 7.94655706237675, 1.8055818935480081, 'UPHENO:0085118', 'abnormal hematopoietic cell morphology'),
(215039, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0001588', 'abnormal hemoglobin', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(215040, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0012376', 'abnormal erythrocyte potassium ion content', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(215041, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0010067', 'increased red blood cell distribution width', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(215042, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0011180', 'abnormal hematopoietic cell number', 0.41025641025641024, 7.94655706237675, 1.8055818935480081, 'UPHENO:0085118', 'abnormal hematopoietic cell morphology'),
(215043, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0005642', 'decreased mean corpuscular hemoglobin concentration', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(215044, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0002877', 'abnormal melanocyte morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(215045, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0002814', 'hyperchromasia', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(215046, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0002608', 'increased hematocrit', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(215047, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0012378', 'increased erythrocyte potassium ion content', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(215048, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0010068', 'decreased red blood cell distribution width', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(215049, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0012377', 'decreased erythrocyte potassium ion content', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(215050, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0009395', 'increased nucleated erythrocyte cell number', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(215051, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0012397', 'abnormal nucleated erythrocyte cell number', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(215052, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0011171', 'increased number of Heinz bodies', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(215053, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0005097', 'polychromatophilia', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(215054, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0013659', 'abnormal erythroid lineage cell morphology', 0.47368421052631576, 10.15319077934013, 2.1930358315893517, 'UPHENO:0088170', 'abnormal erythroid lineage cell morphology'),
(215055, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0003902', 'abnormal cell mass', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(215056, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0013702', 'abnormal megakaryocyte-erythroid progenitor cell morphology', 0.425, 9.052558416233639, 1.9614630577452374, 'UPHENO:0085068', 'abnormal myeloid cell morphology'),
(215057, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0012398', 'decreased nucleated erythrocyte cell number', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(215058, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0012379', 'abnormal erythrocyte sodium ion content', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(215059, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0010066', 'abnormal red blood cell distribution width', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(215060, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0010175', 'leptocytosis', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(215061, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0013656', 'abnormal hematopoietic cell morphology', 0.45714285714285713, 7.94655706237675, 1.9059674183846, 'UPHENO:0085118', 'abnormal hematopoietic cell morphology'),
(215062, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0002642', 'anisocytosis', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(215063, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0002447', 'abnormal erythrocyte morphology', 0.4318181818181818, 10.352905980535489, 2.114372965455578, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(215064, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0002424', 'abnormal reticulocyte morphology', 0.45, 10.15319077934013, 2.1375069241298514, 'UPHENO:0088170', 'abnormal erythroid lineage cell morphology'),
(215065, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0010696', 'increased siderocyte number', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(215066, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0010178', 'increased number of Howell-Jolly bodies', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(215067, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0012381', 'increased erythrocyte sodium ion content', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(215068, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0009840', 'abnormal foam cell morphology', 0.42424242424242425, 6.121988824155609, 1.6115853622891974, 'UPHENO:0084928', 'abnormal cell morphology'),
(215069, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0004808', 'abnormal hematopoietic stem cell morphology', 0.41025641025641024, 7.94655706237675, 1.8055818935480081, 'UPHENO:0085118', 'abnormal hematopoietic cell morphology'),
(215070, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0009568', 'abnormal red blood cell deformability', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(215071, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0009547', 'elliptocytosis', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(215072, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0005641', 'increased mean corpuscular hemoglobin concentration', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(215073, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0005640', 'abnormal mean corpuscular hemoglobin concentration', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(215074, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0010177', 'acanthocytosis', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(215075, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0013661', 'abnormal myeloid cell number', 0.40476190476190477, 9.052558416233639, 1.9141919411394301, 'UPHENO:0085068', 'abnormal myeloid cell morphology'),
(215076, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0013658', 'abnormal myeloid cell morphology', 0.4722222222222222, 9.052558416233639, 2.0675636029177746, 'UPHENO:0085068', 'abnormal myeloid cell morphology'),
(215077, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0012374', 'decreased erythrocyte magnesium ion content', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(215078, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0012373', 'abnormal erythrocyte magnesium ion content', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(215079, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0013707', 'abnormal hematopoietic precursor cell morphology', 0.43243243243243246, 7.94655706237675, 1.853739194155074, 'UPHENO:0085118', 'abnormal hematopoietic cell morphology'),
(215080, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0012380', 'decreased erythrocyte sodium ion content', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(215081, 'HP:0020080', 'Erythrocyte inclusion bodies', 'MP:0012375', 'increased erythrocyte magnesium ion content', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(215082, 'HP:0030258', 'Hyperpigmented genitalia', 'MP:0002160', 'abnormal reproductive system morphology', 0.41379310344827586, 7.392828147110509, 1.749028673936658, 'UPHENO:0087547', 'abnormal reproductive system morphology'),
(215083, 'HP:0030258', 'Hyperpigmented genitalia', 'MP:0001116', 'small gonad', 0.4166666666666667, 7.392828147110509, 1.7550911831856615, 'UPHENO:0087547', 'abnormal reproductive system morphology'),
(215084, 'HP:0030258', 'Hyperpigmented genitalia', 'MP:0003956', 'abnormal body size', 0.40625, 3.067140347159989, 1.1162552423320329, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(215085, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0003349', 'abnormal circulating renin level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215086, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0013255', 'abnormal circulating thrombin level', 0.5384615384615384, 9.555485148088783, 2.268316828308221, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215087, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0031081', 'abnormal circulating D-dimer level', 0.5384615384615384, 9.555485148088783, 2.268316828308221, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215088, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0012615', 'decreased circulating factor IX level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215089, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0030744', 'abnormal circulating homocitrulline level', 0.4318181818181818, 8.001050554100775, 1.8587627882296205, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(215090, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0001569', 'abnormal circulating bilirubin level', 0.4523809523809524, 8.001050554100775, 1.9025043678562883, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(215091, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0008616', 'abnormal circulating interleukin-12 level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215092, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0031076', 'decreased circulating troponin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215093, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0011893', 'increased circulating transferrin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215094, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0001570', 'abnormal circulating enzyme level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215095, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0005419', 'decreased circulating serum albumin level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215096, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0010333', 'abnormal circulating apolipoprotein E level', 0.42857142857142855, 9.555485148088783, 2.023662007502606, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215097, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0008619', 'abnormal circulating interleukin-23 level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215098, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0031075', 'abnormal circulating troponin level', 0.5384615384615384, 9.555485148088783, 2.268316828308221, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215099, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0031164', 'decreased circulating von Willebrand factor level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215100, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0001560', 'abnormal circulating insulin level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(215101, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0010214', 'abnormal circulating serum amyloid protein level', 0.42857142857142855, 9.555485148088783, 2.023662007502606, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215102, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0031059', 'increased circulating C-reactive protein level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215103, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0011892', 'abnormal circulating transferrin level', 0.5384615384615384, 9.555485148088783, 2.268316828308221, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215104, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0011894', 'decreased circulating transferrin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215105, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0031077', 'increased circulating troponin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215106, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0030625', 'increased circulating cysteine level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(215107, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0012333', 'increased circulating fibronectin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215108, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0005663', 'abnormal circulating noradrenaline level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(215109, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0002965', 'increased circulating serum albumin level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215110, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0020985', 'increased circulating factor XI level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215111, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0012327', 'abnormal circulating factor VIII level', 0.5384615384615384, 9.555485148088783, 2.268316828308221, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215112, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0021034', 'abnormal circulating cartilage oligomeric matrix protein level', 0.5384615384615384, 9.555485148088783, 2.268316828308221, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215113, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0013257', 'decreased circulating thrombin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215114, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0012619', 'increased circulating factor X level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215115, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0010332', 'abnormal circulating apolipoprotein level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215116, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0012620', 'abnormal circulating factor XIII level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215117, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0031083', 'increased circulating D-dimer level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215118, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0005566', 'decreased blood urea nitrogen level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(215119, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0020255', 'absent circulating factor XII protein', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215120, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0011972', 'decreased circulating lactate dehydrogenase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215121, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0000202', 'abnormal circulating alkaline phosphatase level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215122, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0013277', 'abnormal fasting circulating glucose level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(215123, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0012330', 'decreased circulating fibrinogen level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215124, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0000199', 'abnormal circulating serum albumin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215125, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0008806', 'increased circulating amylase level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215126, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0020984', 'decreased circulating factor XI level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215127, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0012618', 'decreased circulating factor X level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215128, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0012329', 'increased circulating factor VIII level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215129, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0031072', 'abnormal circulating type I collagen C-terminal telopeptide level', 0.5384615384615384, 9.555485148088783, 2.268316828308221, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215130, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0012622', 'increased circulating factor XIII level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215131, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0005311', 'abnormal circulating amino acid level', 0.4418604651162791, 8.001050554100775, 1.880252089283198, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(215132, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0004700', 'abnormal circulating insulin-like growth factor I level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(215133, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0009699', 'hyperchylomicronemia', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(215134, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0005567', 'decreased circulating total protein level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215135, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0012221', 'abnormal circulating prothrombin level', 0.5384615384615384, 9.555485148088783, 2.268316828308221, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215136, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0000188', 'abnormal circulating glucose level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(215137, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0031108', 'increased circulating myoglobin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215138, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0005667', 'abnormal circulating leptin level', 0.4318181818181818, 8.001050554100775, 1.8587627882296205, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(215139, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0020341', 'abnormal circulating hyaluronic acid level', 0.4523809523809524, 8.001050554100775, 1.9025043678562883, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(215140, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0002695', 'abnormal circulating glucagon level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(215141, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0011284', 'abnormal circulating erythropoietin level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(215142, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0021038', 'increased circulating orosomucoid 1 protein level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215143, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0013403', 'abnormal circulating lactate level', 0.425, 7.550058075704454, 1.791305301218749, 'UPHENO:0076286', 'abnormal role blood level'),
(215144, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0020258', 'decreased circulating factor XII level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215145, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0010215', 'abnormal circulating complement protein level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215146, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0012614', 'abnormal circulating factor IX level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215147, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0010091', 'decreased circulating creatine kinase level', 0.42857142857142855, 9.555485148088783, 2.023662007502606, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215148, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0030672', 'abnormal circulating alanine level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(215149, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0005328', 'abnormal circulating creatinine level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(215150, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0012664', 'decreased circulating haptoglobin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215151, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0030626', 'decreased circulating cysteine level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(215152, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0031243', 'abnormal circulating CSF3 level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215153, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0012661', 'decreased circulating ceruloplasmin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215154, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0030745', 'increased circulating homocitrulline level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(215155, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0008549', 'abnormal circulating interferon-alpha level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215156, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0012331', 'increased circulating fibrinogen level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215157, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0031233', 'decreased circulating serum amyloid protein level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215158, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0005632', 'decreased circulating aspartate transaminase level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215159, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0010210', 'abnormal circulating cytokine level', 0.42857142857142855, 9.555485148088783, 2.023662007502606, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215160, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0008804', 'abnormal circulating amylase level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215161, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0011912', 'abnormal circulating fibronectin level', 0.5384615384615384, 9.555485148088783, 2.268316828308221, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215162, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0002329', 'abnormal blood gas level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(215163, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0031165', 'increased circulating von Willebrand factor level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215164, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0008459', 'abnormal circulating pancreatic peptide level', 0.4318181818181818, 8.001050554100775, 1.8587627882296205, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(215165, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0031234', 'increased circulating serum amyloid protein level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215166, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0031340', 'abnormal circulating lipocalin 2 level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215167, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0005521', 'abnormal circulating atrial natriuretic factor level', 0.4318181818181818, 8.001050554100775, 1.8587627882296205, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(215168, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0010212', 'abnormal circulating C-reactive protein level', 0.42857142857142855, 9.555485148088783, 2.023662007502606, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215169, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0008588', 'abnormal circulating interleukin level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215170, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0031079', 'increased circulating troponin I level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215171, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0012617', 'abnormal circulating factor X level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215172, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0011889', 'abnormal circulating ferritin level', 0.5384615384615384, 9.555485148088783, 2.268316828308221, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215173, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0012326', 'increased circulating antithrombin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215174, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0031078', 'increased circulating troponin T level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215175, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0010213', 'abnormal circulating fibrinogen level', 0.42857142857142855, 9.555485148088783, 2.023662007502606, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215176, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0006373', 'abnormal circulating angiotensinogen level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215177, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0020248', 'decreased circulating arginase level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215178, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0010090', 'increased circulating creatine kinase level', 0.42857142857142855, 9.555485148088783, 2.023662007502606, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215179, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0012616', 'increased circulating factor IX level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215180, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0002942', 'decreased circulating alanine transaminase level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215181, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0010106', 'abnormal circulating pyruvate kinase level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215182, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0031163', 'abnormal circulating von Willebrand factor level', 0.5384615384615384, 9.555485148088783, 2.268316828308221, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215183, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0020216', 'decreased circulating complement protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215184, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0020257', 'increased circulating factor XII level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215185, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0012223', 'increased circulating prothrombin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215186, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0011611', 'abnormal circulating ghrelin level', 0.4418604651162791, 8.001050554100775, 1.880252089283198, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(215187, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0031341', 'decreased circulating lipocalin 2 level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215188, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0011887', 'decreased circulating lipase level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215189, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0005416', 'abnormal circulating protein level', 0.5526315789473685, 9.555485148088783, 2.2979692872178323, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215190, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0012666', 'increased circulating haptoglobin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215191, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0011888', 'abnormal circulating total protein level', 0.5384615384615384, 9.555485148088783, 2.268316828308221, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215192, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0012222', 'decreased circulating prothrombin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215193, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0002903', 'abnormal circulating parathyroid hormone level', 0.4318181818181818, 8.001050554100775, 1.8587627882296205, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(215194, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0010089', 'abnormal circulating creatine kinase level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215195, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0020247', 'increased circulating arginase level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215196, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0008820', 'abnormal blood uric acid level', 0.48717948717948717, 8.001050554100775, 1.9743220876655276, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(215197, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0020217', 'increased circulating complement protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215198, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0005308', 'abnormal circulating ammonia level', 0.4523809523809524, 8.001050554100775, 1.9025043678562883, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(215199, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0011970', 'abnormal circulating lactate dehydrogenase level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215200, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0010209', 'abnormal circulating chemokine level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215201, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0011897', 'decreased circulating unsaturated transferrin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215202, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0004730', 'abnormal circulating gastrin level', 0.4318181818181818, 8.001050554100775, 1.8587627882296205, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(215203, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0011895', 'abnormal circulating unsaturated transferrin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215204, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0021037', 'abnormal circulating orosomucoid 1 protein level', 0.42857142857142855, 9.555485148088783, 2.023662007502606, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215205, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0021035', 'decreased circulating cartilage oligomeric matrix protein level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215206, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0012324', 'abnormal circulating antithrombin level', 0.5384615384615384, 9.555485148088783, 2.268316828308221, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215207, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0011008', 'abnormal circulating glutamate dehydrogenase level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215208, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0012332', 'decreased circulating fibronectin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215209, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0031074', 'increased circulating type I collagen C-terminal telopeptide level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215210, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0011890', 'increased circulating ferritin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215211, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0013256', 'increased circulating thrombin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215212, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0011885', 'abnormal circulating lipase level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215213, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0012328', 'decreased circulating factor VIII level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215214, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0021036', 'increased circulating cartilage oligomeric matrix protein level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215215, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0030757', 'abnormal circulating histamine level', 0.4523809523809524, 8.001050554100775, 1.9025043678562883, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(215216, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0012325', 'decreased circulating antithrombin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215217, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0012621', 'decreased circulating factor XIII level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215218, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0031107', 'abnormal circulating myoglobin level', 0.5384615384615384, 9.555485148088783, 2.268316828308221, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215219, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0031073', 'decreased circulating type I collagen C-terminal telopeptide level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215220, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0001573', 'abnormal circulating alanine transaminase level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215221, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0010216', 'abnormal circulating retinol binding protein level', 0.5384615384615384, 9.555485148088783, 2.268316828308221, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215222, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0011896', 'increased circulating unsaturated transferrin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215223, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0031064', 'abnormal circulating procalcitonin level', 0.5384615384615384, 9.555485148088783, 2.268316828308221, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215224, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0011891', 'decreased circulating ferritin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215225, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0020256', 'abnormal circulating factor XII level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215226, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0031342', 'increased circulating lipocalin 2 level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215227, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0012662', 'increased circulating ceruloplasmin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215228, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0020983', 'abnormal circulating factor XI level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215229, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0010330', 'abnormal circulating lipoprotein level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(215230, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0011886', 'increased circulating lipase level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215231, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0002941', 'increased circulating alanine transaminase level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215232, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0011971', 'increased circulating lactate dehydrogenase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215233, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0021039', 'decreased circulating orosomucoid 1 protein level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215234, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0030624', 'abnormal circulating cysteine level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(215235, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0031114', 'increased circulating gamma-glutamyl transferase level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215236, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0020246', 'abnormal circulating arginase level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215237, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0005265', 'abnormal blood urea nitrogen level', 0.48717948717948717, 8.001050554100775, 1.9743220876655276, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(215238, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0031065', 'increased circulating procalcitonin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215239, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0031060', 'decreased circulating C-reactive protein level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215240, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0031082', 'decreased circulating D-dimer level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215241, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0020986', 'abnormal circulating ceruloplasmin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215242, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0008548', 'abnormal circulating interferon level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215243, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0000203', 'abnormal circulating aspartate transaminase level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215244, 'HP:0010876', 'Abnormal circulating protein concentration', 'MP:0008805', 'decreased circulating amylase level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(215245, 'HP:0001048', 'Cavernous hemangioma', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.4074074074074074, 7.347404004220494, 1.7301406926993756, 'UPHENO:0080362', 'abnormal cardiovascular system'),
(215246, 'HP:0033415', 'Cardiac tamponade', 'MP:0011927', 'abnormal cardiac valve flow', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215247, 'HP:0033415', 'Cardiac tamponade', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215248, 'HP:0033415', 'Cardiac tamponade', 'MP:0004781', 'abnormal surfactant composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215249, 'HP:0033415', 'Cardiac tamponade', 'MP:0006203', 'eye hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215250, 'HP:0033415', 'Cardiac tamponade', 'MP:0002292', 'abnormal gestational length', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215251, 'HP:0033415', 'Cardiac tamponade', 'MP:0008678', 'increased interleukin-16 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215252, 'HP:0033415', 'Cardiac tamponade', 'MP:0003041', 'increased time of onset of induced ischemic contracture', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215253, 'HP:0033415', 'Cardiac tamponade', 'MP:0010752', 'impaired mucociliary clearance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215254, 'HP:0033415', 'Cardiac tamponade', 'MP:0005576', 'decreased pulmonary ventilation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215255, 'HP:0033415', 'Cardiac tamponade', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215256, 'HP:0033415', 'Cardiac tamponade', 'MP:0011194', 'abnormal hair follicle physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215257, 'HP:0033415', 'Cardiac tamponade', 'MP:0004759', 'decreased mitotic index', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215258, 'HP:0033415', 'Cardiac tamponade', 'MP:0030153', 'dental pulp inflammation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215259, 'HP:0033415', 'Cardiac tamponade', 'MP:0010756', 'decreased right ventricle peak pressure', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215260, 'HP:0033415', 'Cardiac tamponade', 'MP:0031126', 'gangrene', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215261, 'HP:0033415', 'Cardiac tamponade', 'MP:0004748', 'increased susceptibility to age-related hearing loss', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215262, 'HP:0033415', 'Cardiac tamponade', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215263, 'HP:0033415', 'Cardiac tamponade', 'MP:0012305', 'umbilical cord hemorrhage', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215264, 'HP:0033415', 'Cardiac tamponade', 'MP:0009276', 'ecchymosis', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215265, 'HP:0033415', 'Cardiac tamponade', 'MP:0006150', 'double vision', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215266, 'HP:0033415', 'Cardiac tamponade', 'MP:0010680', 'abnormal skin adnexa physiology', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215267, 'HP:0033415', 'Cardiac tamponade', 'MP:0012034', 'abnormal a-wave shape', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215268, 'HP:0033415', 'Cardiac tamponade', 'MP:0004021', 'abnormal rod electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215269, 'HP:0033415', 'Cardiac tamponade', 'MP:0013145', 'eye discharge', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215270, 'HP:0033415', 'Cardiac tamponade', 'MP:0011417', 'abnormal renal transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215271, 'HP:0033415', 'Cardiac tamponade', 'MP:0004145', 'abnormal muscle electrophysiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215272, 'HP:0033415', 'Cardiac tamponade', 'MP:0004876', 'decreased mean systemic arterial blood pressure', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215273, 'HP:0033415', 'Cardiac tamponade', 'MP:0031117', 'subdural hemorrhage', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215274, 'HP:0033415', 'Cardiac tamponade', 'MP:0008748', 'abnormal central T cell anergy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215275, 'HP:0033415', 'Cardiac tamponade', 'MP:0020848', 'abnormal exocytosis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215276, 'HP:0033415', 'Cardiac tamponade', 'MP:0006265', 'increased pulse pressure', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215277, 'HP:0033415', 'Cardiac tamponade', 'MP:0009732', 'ventricular premature beat', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215278, 'HP:0033415', 'Cardiac tamponade', 'MP:0009473', 'abnormal skin exfoliation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215279, 'HP:0033415', 'Cardiac tamponade', 'MP:0004003', 'abnormal vascular endothelial cell physiology', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215280, 'HP:0033415', 'Cardiac tamponade', 'MP:0003375', 'abnormal menstrual cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215281, 'HP:0033415', 'Cardiac tamponade', 'MP:0031153', 'stomach hemorrhage', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215282, 'HP:0033415', 'Cardiac tamponade', 'MP:0010392', 'prolonged QRS complex duration', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215283, 'HP:0033415', 'Cardiac tamponade', 'MP:0005000', 'abnormal immune tolerance', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215284, 'HP:0033415', 'Cardiac tamponade', 'MP:0003866', 'abnormal defecation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215285, 'HP:0033415', 'Cardiac tamponade', 'MP:0011702', 'abnormal fibroblast proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215286, 'HP:0033415', 'Cardiac tamponade', 'MP:0008706', 'decreased interleukin-6 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215287, 'HP:0033415', 'Cardiac tamponade', 'MP:0004213', 'abnormal umami taste sensitivity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215288, 'HP:0033415', 'Cardiac tamponade', 'MP:0006334', 'abnormal susceptibility to hearing loss', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215289, 'HP:0033415', 'Cardiac tamponade', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215290, 'HP:0033415', 'Cardiac tamponade', 'MP:0009697', 'abnormal copulation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215291, 'HP:0033415', 'Cardiac tamponade', 'MP:0031090', 'ageusia', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215292, 'HP:0033415', 'Cardiac tamponade', 'MP:0012197', 'impaired myofibroblast differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215293, 'HP:0033415', 'Cardiac tamponade', 'MP:0004486', 'decreased response of heart to induced stress', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215294, 'HP:0033415', 'Cardiac tamponade', 'MP:0031089', 'sneezing', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215295, 'HP:0033415', 'Cardiac tamponade', 'MP:0006045', 'mitral valve regurgitation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215296, 'HP:0033415', 'Cardiac tamponade', 'MP:0010570', 'prolonged ST segment', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215297, 'HP:0033415', 'Cardiac tamponade', 'MP:0000533', 'kidney hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215298, 'HP:0033415', 'Cardiac tamponade', 'MP:0014031', 'abnormal submucosal gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215299, 'HP:0033415', 'Cardiac tamponade', 'MP:0003475', 'increased summary potential intensity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215300, 'HP:0033415', 'Cardiac tamponade', 'MP:0008145', 'hemeralopia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215301, 'HP:0033415', 'Cardiac tamponade', 'MP:0030941', 'enhanced autophagy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215302, 'HP:0033415', 'Cardiac tamponade', 'MP:0006053', 'hypothalamus hemorrhage', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215303, 'HP:0033415', 'Cardiac tamponade', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215304, 'HP:0033415', 'Cardiac tamponade', 'MP:0001916', 'intracerebral hemorrhage', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215305, 'HP:0033415', 'Cardiac tamponade', 'MP:0001876', 'decreased inflammatory response', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215306, 'HP:0033415', 'Cardiac tamponade', 'MP:0013634', 'increased femur fracture load', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215307, 'HP:0033415', 'Cardiac tamponade', 'MP:0009762', 'abnormal mitotic spindle assembly checkpoint', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215308, 'HP:0033415', 'Cardiac tamponade', 'MP:0010510', 'absent P wave', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215309, 'HP:0033415', 'Cardiac tamponade', 'MP:0013475', 'delayed reproductive senescence', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215310, 'HP:0033415', 'Cardiac tamponade', 'MP:0020371', 'abnormal glymphatic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215311, 'HP:0033415', 'Cardiac tamponade', 'MP:0031469', 'abnormal pinocytosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215312, 'HP:0033415', 'Cardiac tamponade', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215313, 'HP:0033415', 'Cardiac tamponade', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215314, 'HP:0033415', 'Cardiac tamponade', 'MP:0002896', 'abnormal bone mineralization', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215315, 'HP:0033415', 'Cardiac tamponade', 'MP:0001666', 'abnormal intestinal absorption', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215316, 'HP:0033415', 'Cardiac tamponade', 'MP:0031092', 'dysgeusia', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215317, 'HP:0033415', 'Cardiac tamponade', 'MP:0002578', 'impaired ability to fire action potentials', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215318, 'HP:0033415', 'Cardiac tamponade', 'MP:0004859', 'abnormal synaptic plasticity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215319, 'HP:0033415', 'Cardiac tamponade', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215320, 'HP:0033415', 'Cardiac tamponade', 'MP:0001379', 'abnormal penile erection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215321, 'HP:0033415', 'Cardiac tamponade', 'MP:0004071', 'prolonged P wave', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215322, 'HP:0033415', 'Cardiac tamponade', 'MP:0000505', 'decreased digestive secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215323, 'HP:0033415', 'Cardiac tamponade', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215324, 'HP:0033415', 'Cardiac tamponade', 'MP:0031009', 'abnormal sperm-egg fusion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215325, 'HP:0033415', 'Cardiac tamponade', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215326, 'HP:0033415', 'Cardiac tamponade', 'MP:0000064', 'failure of bone resorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215327, 'HP:0033415', 'Cardiac tamponade', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215328, 'HP:0033415', 'Cardiac tamponade', 'MP:0003186', 'abnormal redox activity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215329, 'HP:0033415', 'Cardiac tamponade', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215330, 'HP:0033415', 'Cardiac tamponade', 'MP:0010741', 'abnormal melanocyte proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215331, 'HP:0033415', 'Cardiac tamponade', 'MP:0011431', 'increased urine flow rate', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215332, 'HP:0033415', 'Cardiac tamponade', 'MP:0003040', 'decreased time of peak ischemic contracture', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215333, 'HP:0033415', 'Cardiac tamponade', 'MP:0013134', 'poor circulation in autopods', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215334, 'HP:0033415', 'Cardiac tamponade', 'MP:0000316', 'cellular necrosis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215335, 'HP:0033415', 'Cardiac tamponade', 'MP:0009349', 'increased urine pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215336, 'HP:0033415', 'Cardiac tamponade', 'MP:0003438', 'abnormal carotid body physiology', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215337, 'HP:0033415', 'Cardiac tamponade', 'MP:0002796', 'impaired skin barrier function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215338, 'HP:0033415', 'Cardiac tamponade', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215339, 'HP:0033415', 'Cardiac tamponade', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215340, 'HP:0033415', 'Cardiac tamponade', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215341, 'HP:0033415', 'Cardiac tamponade', 'MP:0003394', 'increased cardiac output', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215342, 'HP:0033415', 'Cardiac tamponade', 'MP:0008410', 'increased cellular sensitivity to ultraviolet irradiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215343, 'HP:0033415', 'Cardiac tamponade', 'MP:0030988', 'dysosmia', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215344, 'HP:0033415', 'Cardiac tamponade', 'MP:0005044', 'sepsis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215345, 'HP:0033415', 'Cardiac tamponade', 'MP:0005036', 'diarrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215346, 'HP:0033415', 'Cardiac tamponade', 'MP:0000948', 'nonconvulsive seizures', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215347, 'HP:0033415', 'Cardiac tamponade', 'MP:0008664', 'decreased interleukin-12 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215348, 'HP:0033415', 'Cardiac tamponade', 'MP:0009045', 'muscle tetany', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215349, 'HP:0033415', 'Cardiac tamponade', 'MP:0002907', 'abnormal parturition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215350, 'HP:0033415', 'Cardiac tamponade', 'MP:0001921', 'reduced fertility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215351, 'HP:0033415', 'Cardiac tamponade', 'MP:0031102', 'rhinorrhea', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215352, 'HP:0033415', 'Cardiac tamponade', 'MP:0006051', 'brainstem hemorrhage', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215353, 'HP:0033415', 'Cardiac tamponade', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215354, 'HP:0033415', 'Cardiac tamponade', 'MP:0020155', 'enhanced humoral immune response', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215355, 'HP:0033415', 'Cardiac tamponade', 'MP:0001633', 'poor circulation', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215356, 'HP:0033415', 'Cardiac tamponade', 'MP:0004738', 'abnormal auditory brainstem response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215357, 'HP:0033415', 'Cardiac tamponade', 'MP:0013136', 'genital discharge', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215358, 'HP:0033415', 'Cardiac tamponade', 'MP:0012033', 'abnormal ERG implicit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215359, 'HP:0033415', 'Cardiac tamponade', 'MP:0008413', 'decreased cellular sensitivity to oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215360, 'HP:0033415', 'Cardiac tamponade', 'MP:0003820', 'increased left ventricle systolic pressure', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215361, 'HP:0033415', 'Cardiac tamponade', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215362, 'HP:0033415', 'Cardiac tamponade', 'MP:0010631', 'increased Q wave amplitude', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215363, 'HP:0033415', 'Cardiac tamponade', 'MP:0004994', 'abnormal brain wave pattern', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215364, 'HP:0033415', 'Cardiac tamponade', 'MP:0010554', 'shortened HV interval', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215365, 'HP:0033415', 'Cardiac tamponade', 'MP:0020219', 'increased tear production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215366, 'HP:0033415', 'Cardiac tamponade', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215367, 'HP:0033415', 'Cardiac tamponade', 'MP:0000920', 'abnormal myelination', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215368, 'HP:0033415', 'Cardiac tamponade', 'MP:0004149', 'increased bone strength', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215369, 'HP:0033415', 'Cardiac tamponade', 'MP:0003192', 'increased cholesterol efflux', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215370, 'HP:0033415', 'Cardiac tamponade', 'MP:0011954', 'shortened PQ interval', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215371, 'HP:0033415', 'Cardiac tamponade', 'MP:0030216', 'tongue muscle fasciculation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215372, 'HP:0033415', 'Cardiac tamponade', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215373, 'HP:0033415', 'Cardiac tamponade', 'MP:0008679', 'decreased interleukin-16 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215374, 'HP:0033415', 'Cardiac tamponade', 'MP:0020097', 'low mean heart rate adaptation', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215375, 'HP:0033415', 'Cardiac tamponade', 'MP:0001915', 'intracranial hemorrhage', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215376, 'HP:0033415', 'Cardiac tamponade', 'MP:0004227', 'increased cellular sensitivity to ionizing radiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215377, 'HP:0033415', 'Cardiac tamponade', 'MP:0011390', 'abnormal fetal cardiomyocyte physiology', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215378, 'HP:0033415', 'Cardiac tamponade', 'MP:0011832', 'abnormal visual acuity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215379, 'HP:0033415', 'Cardiac tamponade', 'MP:0005600', 'increased ventricle muscle contractility', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215380, 'HP:0033415', 'Cardiac tamponade', 'MP:0013556', 'abnormal holocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215381, 'HP:0033415', 'Cardiac tamponade', 'MP:0001846', 'increased inflammatory response', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215382, 'HP:0033415', 'Cardiac tamponade', 'MP:0011923', 'abnormal bladder urine volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215383, 'HP:0033415', 'Cardiac tamponade', 'MP:0003034', 'increased pulmonary vascular resistance', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215384, 'HP:0033415', 'Cardiac tamponade', 'MP:0004760', 'increased mitotic index', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215385, 'HP:0033415', 'Cardiac tamponade', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215386, 'HP:0033415', 'Cardiac tamponade', 'MP:0005620', 'abnormal muscle contractility', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215387, 'HP:0033415', 'Cardiac tamponade', 'MP:0004752', 'decreased length of allograft survival', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215388, 'HP:0033415', 'Cardiac tamponade', 'MP:0003039', 'increased time of peak ischemic contracture', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215389, 'HP:0033415', 'Cardiac tamponade', 'MP:0012554', 'increased serum complement activity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215390, 'HP:0033415', 'Cardiac tamponade', 'MP:0014241', 'abnormal intracellular organelle physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215391, 'HP:0033415', 'Cardiac tamponade', 'MP:0004512', 'anosmia', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215392, 'HP:0033415', 'Cardiac tamponade', 'MP:0003431', 'abnormal parathyroid gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215393, 'HP:0033415', 'Cardiac tamponade', 'MP:0003463', 'abnormal single cell response', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215394, 'HP:0033415', 'Cardiac tamponade', 'MP:0008412', 'increased cellular sensitivity to oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215395, 'HP:0033415', 'Cardiac tamponade', 'MP:0011805', 'decreased cell migration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215396, 'HP:0033415', 'Cardiac tamponade', 'MP:0004245', 'genital hemorrhage', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215397, 'HP:0033415', 'Cardiac tamponade', 'MP:0006111', 'abnormal coronary circulation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215398, 'HP:0033415', 'Cardiac tamponade', 'MP:0000423', 'delayed hair regrowth', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215399, 'HP:0033415', 'Cardiac tamponade', 'MP:0012125', 'decreased bronchoconstrictive response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215400, 'HP:0033415', 'Cardiac tamponade', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215401, 'HP:0033415', 'Cardiac tamponade', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215402, 'HP:0033415', 'Cardiac tamponade', 'MP:0003033', 'abnormal pulmonary vascular resistance', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215403, 'HP:0033415', 'Cardiac tamponade', 'MP:0010895', 'increased lung compliance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215404, 'HP:0033415', 'Cardiac tamponade', 'MP:0009562', 'abnormal odor adaptation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215405, 'HP:0033415', 'Cardiac tamponade', 'MP:0001533', 'abnormal skeleton physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215406, 'HP:0033415', 'Cardiac tamponade', 'MP:0008558', 'abnormal interferon-beta secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215407, 'HP:0033415', 'Cardiac tamponade', 'MP:0003037', 'increased myocardial infarct size', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215408, 'HP:0033415', 'Cardiac tamponade', 'MP:0008661', 'decreased interleukin-10 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215409, 'HP:0033415', 'Cardiac tamponade', 'MP:0002893', 'ketoaciduria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215410, 'HP:0033415', 'Cardiac tamponade', 'MP:0008005', 'decreased stomach pH', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215411, 'HP:0033415', 'Cardiac tamponade', 'MP:0010511', 'shortened PR interval', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215412, 'HP:0033415', 'Cardiac tamponade', 'MP:0001752', 'abnormal hypothalamus secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215413, 'HP:0033415', 'Cardiac tamponade', 'MP:0031484', 'increased urine hypoxanthine level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215414, 'HP:0033415', 'Cardiac tamponade', 'MP:0003548', 'pulmonary hypertension', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215415, 'HP:0033415', 'Cardiac tamponade', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215416, 'HP:0033415', 'Cardiac tamponade', 'MP:0003589', 'abnormal ureter physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215417, 'HP:0033415', 'Cardiac tamponade', 'MP:0013627', 'increased vertebra yield load', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215418, 'HP:0033415', 'Cardiac tamponade', 'MP:0014120', 'focal seizures', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215419, 'HP:0033415', 'Cardiac tamponade', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215420, 'HP:0033415', 'Cardiac tamponade', 'MP:0002330', 'abnormal bronchial provocation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215421, 'HP:0033415', 'Cardiac tamponade', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215422, 'HP:0033415', 'Cardiac tamponade', 'MP:0014275', 'increased respiration', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215423, 'HP:0033415', 'Cardiac tamponade', 'MP:0002472', 'impaired complement alternative pathway', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215424, 'HP:0033415', 'Cardiac tamponade', 'MP:0001854', 'atrial endocarditis', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215425, 'HP:0033415', 'Cardiac tamponade', 'MP:0031104', 'crackles', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215426, 'HP:0033415', 'Cardiac tamponade', 'MP:0031155', 'small intestine hemorrhage', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215427, 'HP:0033415', 'Cardiac tamponade', 'MP:0010514', 'fragmented QRS complex', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215428, 'HP:0033415', 'Cardiac tamponade', 'MP:0014040', 'increased cellular sensitivity to DNA damaging agents', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215429, 'HP:0033415', 'Cardiac tamponade', 'MP:0003464', 'abnormal single cell response threshold', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215430, 'HP:0033415', 'Cardiac tamponade', 'MP:0031105', 'rhonchi', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215431, 'HP:0033415', 'Cardiac tamponade', 'MP:0011938', 'prolonged PP interval', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215432, 'HP:0033415', 'Cardiac tamponade', 'MP:0002294', 'short gestation period', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215433, 'HP:0033415', 'Cardiac tamponade', 'MP:0005595', 'abnormal vascular smooth muscle physiology', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215434, 'HP:0033415', 'Cardiac tamponade', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215435, 'HP:0033415', 'Cardiac tamponade', 'MP:0004597', 'increased susceptibility to noise-induced hearing loss', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215436, 'HP:0033415', 'Cardiac tamponade', 'MP:0002500', 'granulomatous inflammation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215437, 'HP:0033415', 'Cardiac tamponade', 'MP:0031169', 'abnormal joint physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215438, 'HP:0033415', 'Cardiac tamponade', 'MP:0006144', 'increased systemic arterial systolic blood pressure', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215439, 'HP:0033415', 'Cardiac tamponade', 'MP:0001953', 'respiratory failure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215440, 'HP:0033415', 'Cardiac tamponade', 'MP:0005598', 'decreased ventricle muscle contractility', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215441, 'HP:0033415', 'Cardiac tamponade', 'MP:0012745', 'abnormal neural crest cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215442, 'HP:0033415', 'Cardiac tamponade', 'MP:0003260', 'vomiting', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215443, 'HP:0033415', 'Cardiac tamponade', 'MP:0020154', 'impaired humoral immune response', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215444, 'HP:0033415', 'Cardiac tamponade', 'MP:0003547', 'abnormal pulmonary pressure', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215445, 'HP:0033415', 'Cardiac tamponade', 'MP:0002293', 'long gestation period', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215446, 'HP:0033415', 'Cardiac tamponade', 'MP:0001985', 'abnormal gustatory system physiology', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215447, 'HP:0033415', 'Cardiac tamponade', 'MP:0010957', 'abnormal aerobic respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215448, 'HP:0033415', 'Cardiac tamponade', 'MP:0005666', 'abnormal adipose tissue physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215449, 'HP:0033415', 'Cardiac tamponade', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215450, 'HP:0033415', 'Cardiac tamponade', 'MP:0002723', 'abnormal immune serum protein physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215451, 'HP:0033415', 'Cardiac tamponade', 'MP:0004485', 'increased response of heart to induced stress', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215452, 'HP:0033415', 'Cardiac tamponade', 'MP:0006190', 'retina ischemia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215453, 'HP:0033415', 'Cardiac tamponade', 'MP:0006153', 'hypermetropia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215454, 'HP:0033415', 'Cardiac tamponade', 'MP:0003470', 'abnormal summary potential', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215455, 'HP:0033415', 'Cardiac tamponade', 'MP:0003473', 'decreased summary potential threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215456, 'HP:0033415', 'Cardiac tamponade', 'MP:0013210', 'abnormal primary cilium physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215457, 'HP:0033415', 'Cardiac tamponade', 'MP:0011717', 'increased interleukin-8 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215458, 'HP:0033415', 'Cardiac tamponade', 'MP:0012697', 'abnormal maternal body weight gain', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215459, 'HP:0033415', 'Cardiac tamponade', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215460, 'HP:0033415', 'Cardiac tamponade', 'MP:0005025', 'abnormal response to infection', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215461, 'HP:0033415', 'Cardiac tamponade', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215462, 'HP:0033415', 'Cardiac tamponade', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215463, 'HP:0033415', 'Cardiac tamponade', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215464, 'HP:0033415', 'Cardiac tamponade', 'MP:0003035', 'decreased pulmonary vascular resistance', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215465, 'HP:0033415', 'Cardiac tamponade', 'MP:0000751', 'myopathy', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215466, 'HP:0033415', 'Cardiac tamponade', 'MP:0010513', 'abnormal ventricular activation time', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215467, 'HP:0033415', 'Cardiac tamponade', 'MP:0013135', 'poor circulation in tail', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215468, 'HP:0033415', 'Cardiac tamponade', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215469, 'HP:0033415', 'Cardiac tamponade', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.6363636363636364, 8.605269980670606, 2.3401027534683996, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215470, 'HP:0033415', 'Cardiac tamponade', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215471, 'HP:0033415', 'Cardiac tamponade', 'MP:0003787', 'abnormal imprinting', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215472, 'HP:0033415', 'Cardiac tamponade', 'MP:0031051', 'lymph node hemorrhage', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215473, 'HP:0033415', 'Cardiac tamponade', 'MP:0031480', 'abnormal urine xanthine level', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215474, 'HP:0033415', 'Cardiac tamponade', 'MP:0003549', 'pulmonary hypotension', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215475, 'HP:0033415', 'Cardiac tamponade', 'MP:0003635', 'abnormal synaptic transmission', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215476, 'HP:0033415', 'Cardiac tamponade', 'MP:0008565', 'decreased interferon-beta secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215477, 'HP:0033415', 'Cardiac tamponade', 'MP:0013637', 'increased femur stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215478, 'HP:0033415', 'Cardiac tamponade', 'MP:0030575', 'decreased hair follicle cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215479, 'HP:0033415', 'Cardiac tamponade', 'MP:0014037', 'stranguria', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215480, 'HP:0033415', 'Cardiac tamponade', 'MP:0006263', 'decreased systemic arterial diastolic blood pressure', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215481, 'HP:0033415', 'Cardiac tamponade', 'MP:0003875', 'abnormal hair follicle regression', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215482, 'HP:0033415', 'Cardiac tamponade', 'MP:0008877', 'abnormal DNA methylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215483, 'HP:0033415', 'Cardiac tamponade', 'MP:0003123', 'paternal imprinting', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215484, 'HP:0033415', 'Cardiac tamponade', 'MP:0006332', 'abnormal cochlear potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215485, 'HP:0033415', 'Cardiac tamponade', 'MP:0008069', 'abnormal joint mobility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215486, 'HP:0033415', 'Cardiac tamponade', 'MP:0020381', 'muscle gating pore current', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215487, 'HP:0033415', 'Cardiac tamponade', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215488, 'HP:0033415', 'Cardiac tamponade', 'MP:0008008', 'early cellular replicative senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215489, 'HP:0033415', 'Cardiac tamponade', 'MP:0011825', 'decreased cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215490, 'HP:0033415', 'Cardiac tamponade', 'MP:0011046', 'abnormal lung tissue damping', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215491, 'HP:0033415', 'Cardiac tamponade', 'MP:0006112', 'angina', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215492, 'HP:0033415', 'Cardiac tamponade', 'MP:0003207', 'decreased cellular sensitivity to gamma-irradiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215493, 'HP:0033415', 'Cardiac tamponade', 'MP:0003901', 'abnormal PR interval', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215494, 'HP:0033415', 'Cardiac tamponade', 'MP:0009046', 'muscle twitch', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215495, 'HP:0033415', 'Cardiac tamponade', 'MP:0013632', 'increased femur maximal load', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215496, 'HP:0033415', 'Cardiac tamponade', 'MP:0003042', 'decreased time of onset of induced ischemic contracture', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215497, 'HP:0033415', 'Cardiac tamponade', 'MP:0004743', 'abnormal vestibular evoked myogenic potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215498, 'HP:0033415', 'Cardiac tamponade', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215499, 'HP:0033415', 'Cardiac tamponade', 'MP:0006049', 'semilunar valve regurgitation', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215500, 'HP:0033415', 'Cardiac tamponade', 'MP:0011397', 'endoneurial edema', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215501, 'HP:0033415', 'Cardiac tamponade', 'MP:0012557', 'decreased calcium uptake by cardiac muscle', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215502, 'HP:0033415', 'Cardiac tamponade', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215503, 'HP:0033415', 'Cardiac tamponade', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215504, 'HP:0033415', 'Cardiac tamponade', 'MP:0003928', 'increased heart rate variability', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215505, 'HP:0033415', 'Cardiac tamponade', 'MP:0002841', 'impaired skeletal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215506, 'HP:0033415', 'Cardiac tamponade', 'MP:0012556', 'increased cell death', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215507, 'HP:0033415', 'Cardiac tamponade', 'MP:0008407', 'decreased cellular sensitivity to hydrogen peroxide', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215508, 'HP:0033415', 'Cardiac tamponade', 'MP:0005551', 'abnormal eye electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215509, 'HP:0033415', 'Cardiac tamponade', 'MP:0008006', 'increased stomach pH', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215510, 'HP:0033415', 'Cardiac tamponade', 'MP:0001636', 'irregular heartbeat', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215511, 'HP:0033415', 'Cardiac tamponade', 'MP:0004925', 'decreased susceptibility to noise-induced hearing loss', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215512, 'HP:0033415', 'Cardiac tamponade', 'MP:0005245', 'hemarthrosis', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215513, 'HP:0033415', 'Cardiac tamponade', 'MP:0020425', 'abnormal retinal bipolar cell electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215514, 'HP:0033415', 'Cardiac tamponade', 'MP:0009344', 'abnormal ovulation cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215515, 'HP:0033415', 'Cardiac tamponade', 'MP:0012040', 'abnormal c-wave shape', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215516, 'HP:0033415', 'Cardiac tamponade', 'MP:0011219', 'abnormal intestinal calcium absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215517, 'HP:0033415', 'Cardiac tamponade', 'MP:0012201', 'decreased endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215518, 'HP:0033415', 'Cardiac tamponade', 'MP:0001984', 'abnormal olfaction', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215519, 'HP:0033415', 'Cardiac tamponade', 'MP:0008272', 'abnormal endochondral bone ossification', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215520, 'HP:0033415', 'Cardiac tamponade', 'MP:0003469', 'decreased single cell response intensity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215521, 'HP:0033415', 'Cardiac tamponade', 'MP:0006044', 'tricuspid valve regurgitation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215522, 'HP:0033415', 'Cardiac tamponade', 'MP:0004084', 'abnormal cardiac muscle relaxation', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215523, 'HP:0033415', 'Cardiac tamponade', 'MP:0004022', 'abnormal cone electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215524, 'HP:0033415', 'Cardiac tamponade', 'MP:0011444', 'abnormal renal water homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215525, 'HP:0033415', 'Cardiac tamponade', 'MP:0003481', 'decreased nerve fiber response intensity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215526, 'HP:0033415', 'Cardiac tamponade', 'MP:0008543', 'atrial fibrillation', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215527, 'HP:0033415', 'Cardiac tamponade', 'MP:0010552', 'abnormal HV interval', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215528, 'HP:0033415', 'Cardiac tamponade', 'MP:0030939', 'abnormal autophagosome formation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215529, 'HP:0033415', 'Cardiac tamponade', 'MP:0014195', 'abnormal endocrine pancreas secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215530, 'HP:0033415', 'Cardiac tamponade', 'MP:0011994', 'increased nerve conduction velocity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215531, 'HP:0033415', 'Cardiac tamponade', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215532, 'HP:0033415', 'Cardiac tamponade', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215533, 'HP:0033415', 'Cardiac tamponade', 'MP:0008055', 'increased urine osmolality', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215534, 'HP:0033415', 'Cardiac tamponade', 'MP:0006088', 'abnormal blood-cerebrospinal fluid barrier function', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215535, 'HP:0033415', 'Cardiac tamponade', 'MP:0020138', 'delayed bone mineralization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215536, 'HP:0033415', 'Cardiac tamponade', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215537, 'HP:0033415', 'Cardiac tamponade', 'MP:0020137', 'decreased bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215538, 'HP:0033415', 'Cardiac tamponade', 'MP:0003393', 'decreased cardiac output', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215539, 'HP:0033415', 'Cardiac tamponade', 'MP:0010637', 'sinus bradycardia', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215540, 'HP:0033415', 'Cardiac tamponade', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215541, 'HP:0033415', 'Cardiac tamponade', 'MP:0002909', 'abnormal adrenal gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215542, 'HP:0033415', 'Cardiac tamponade', 'MP:0010028', 'aciduria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215543, 'HP:0033415', 'Cardiac tamponade', 'MP:0013208', 'abnormal cilium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215544, 'HP:0033415', 'Cardiac tamponade', 'MP:0003824', 'decreased left ventricle developed pressure', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215545, 'HP:0033415', 'Cardiac tamponade', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215546, 'HP:0033415', 'Cardiac tamponade', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215547, 'HP:0033415', 'Cardiac tamponade', 'MP:0001947', 'abnormal mucociliary clearance', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215548, 'HP:0033415', 'Cardiac tamponade', 'MP:0013638', 'decreased femur stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215549, 'HP:0033415', 'Cardiac tamponade', 'MP:0000610', 'cholestasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215550, 'HP:0033415', 'Cardiac tamponade', 'MP:0031223', 'increased CXCL10 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215551, 'HP:0033415', 'Cardiac tamponade', 'MP:0008702', 'increased interleukin-5 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215552, 'HP:0033415', 'Cardiac tamponade', 'MP:0004736', 'abnormal distortion product otoacoustic emission', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215553, 'HP:0033415', 'Cardiac tamponade', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215554, 'HP:0033415', 'Cardiac tamponade', 'MP:0014132', 'abnormal tear film physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215555, 'HP:0033415', 'Cardiac tamponade', 'MP:0014183', 'increased respiratory epithelial sodium ion transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215556, 'HP:0033415', 'Cardiac tamponade', 'MP:0003011', 'delayed dark adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215557, 'HP:0033415', 'Cardiac tamponade', 'MP:0001986', 'abnormal taste sensitivity', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215558, 'HP:0033415', 'Cardiac tamponade', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215559, 'HP:0033415', 'Cardiac tamponade', 'MP:0000249', 'abnormal blood vessel physiology', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215560, 'HP:0033415', 'Cardiac tamponade', 'MP:0011043', 'abnormal lung elastance', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215561, 'HP:0033415', 'Cardiac tamponade', 'MP:0012035', 'abnormal b-wave shape', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215562, 'HP:0033415', 'Cardiac tamponade', 'MP:0011022', 'abnormal circadian regulation of systemic arterial blood pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215563, 'HP:0033415', 'Cardiac tamponade', 'MP:0003898', 'abnormal QRS complex', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215564, 'HP:0033415', 'Cardiac tamponade', 'MP:0030909', 'abnormal melanocyte adhesion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215565, 'HP:0033415', 'Cardiac tamponade', 'MP:0008675', 'increased interleukin-15 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215566, 'HP:0033415', 'Cardiac tamponade', 'MP:0006264', 'decreased systemic arterial systolic blood pressure', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215567, 'HP:0033415', 'Cardiac tamponade', 'MP:0031425', 'enhanced male fertility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215568, 'HP:0033415', 'Cardiac tamponade', 'MP:0008699', 'increased interleukin-4 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215569, 'HP:0033415', 'Cardiac tamponade', 'MP:0003293', 'rectal hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215570, 'HP:0033415', 'Cardiac tamponade', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215571, 'HP:0033415', 'Cardiac tamponade', 'MP:0012046', 'decreased susceptibility to hypertension', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215572, 'HP:0033415', 'Cardiac tamponade', 'MP:0008003', 'achlorhydria', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215573, 'HP:0033415', 'Cardiac tamponade', 'MP:0002499', 'chronic inflammation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215574, 'HP:0033415', 'Cardiac tamponade', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215575, 'HP:0033415', 'Cardiac tamponade', 'MP:0030132', 'periodontium inflammation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215576, 'HP:0033415', 'Cardiac tamponade', 'MP:0030924', 'early exit from telogen phase', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215577, 'HP:0033415', 'Cardiac tamponade', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215578, 'HP:0033415', 'Cardiac tamponade', 'MP:0020147', 'abnormal defecation amount', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215579, 'HP:0033415', 'Cardiac tamponade', 'MP:0031136', 'muscle hemorrhage', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215580, 'HP:0033415', 'Cardiac tamponade', 'MP:0008672', 'increased interleukin-13 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215581, 'HP:0033415', 'Cardiac tamponade', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215582, 'HP:0033415', 'Cardiac tamponade', 'MP:0021010', 'impaired synaptic physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215583, 'HP:0033415', 'Cardiac tamponade', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215584, 'HP:0033415', 'Cardiac tamponade', 'MP:0020000', 'abnormal response to antigen', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215585, 'HP:0033415', 'Cardiac tamponade', 'MP:0005530', 'decreased renal vascular resistance', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215586, 'HP:0033415', 'Cardiac tamponade', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215587, 'HP:0033415', 'Cardiac tamponade', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215588, 'HP:0033415', 'Cardiac tamponade', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215589, 'HP:0033415', 'Cardiac tamponade', 'MP:0003566', 'abnormal cell adhesion', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215590, 'HP:0033415', 'Cardiac tamponade', 'MP:0004014', 'abnormal uterine environment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215591, 'HP:0033415', 'Cardiac tamponade', 'MP:0006152', 'tunnel vision', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215592, 'HP:0033415', 'Cardiac tamponade', 'MP:0008705', 'increased interleukin-6 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215593, 'HP:0033415', 'Cardiac tamponade', 'MP:0012558', 'increased calcium uptake by cardiac muscle', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215594, 'HP:0033415', 'Cardiac tamponade', 'MP:0008260', 'abnormal autophagy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215595, 'HP:0033415', 'Cardiac tamponade', 'MP:0005140', 'decreased cardiac muscle contractility', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215596, 'HP:0033415', 'Cardiac tamponade', 'MP:0003929', 'decreased heart rate variability', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215597, 'HP:0033415', 'Cardiac tamponade', 'MP:0004144', 'hypotonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215598, 'HP:0033415', 'Cardiac tamponade', 'MP:0003900', 'shortened QT interval', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215599, 'HP:0033415', 'Cardiac tamponade', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215600, 'HP:0033415', 'Cardiac tamponade', 'MP:0008660', 'increased interleukin-10 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215601, 'HP:0033415', 'Cardiac tamponade', 'MP:0003925', 'abnormal cellular glucose uptake', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215602, 'HP:0033415', 'Cardiac tamponade', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215603, 'HP:0033415', 'Cardiac tamponade', 'MP:0020346', 'abnormal myocardial fiber calcium currents', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215604, 'HP:0033415', 'Cardiac tamponade', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215605, 'HP:0033415', 'Cardiac tamponade', 'MP:0004742', 'abnormal vestibular system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215606, 'HP:0033415', 'Cardiac tamponade', 'MP:0001963', 'abnormal hearing physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215607, 'HP:0033415', 'Cardiac tamponade', 'MP:0005647', 'abnormal sex gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215608, 'HP:0033415', 'Cardiac tamponade', 'MP:0011048', 'decreased lung tissue damping', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215609, 'HP:0033415', 'Cardiac tamponade', 'MP:0003465', 'increased single cell response threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215610, 'HP:0033415', 'Cardiac tamponade', 'MP:0008744', 'abnormal B cell anergy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215611, 'HP:0033415', 'Cardiac tamponade', 'MP:0005330', 'cardiomyopathy', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215612, 'HP:0033415', 'Cardiac tamponade', 'MP:0002335', 'decreased airway responsiveness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215613, 'HP:0033415', 'Cardiac tamponade', 'MP:0004228', 'decreased cellular sensitivity to ionizing radiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215614, 'HP:0033415', 'Cardiac tamponade', 'MP:0000231', 'hypertension', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215615, 'HP:0033415', 'Cardiac tamponade', 'MP:0031306', 'abnormal cartilage physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215616, 'HP:0033415', 'Cardiac tamponade', 'MP:0020218', 'abnormal tear production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215617, 'HP:0033415', 'Cardiac tamponade', 'MP:0004142', 'abnormal muscle tone', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215618, 'HP:0033415', 'Cardiac tamponade', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215619, 'HP:0033415', 'Cardiac tamponade', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215620, 'HP:0033415', 'Cardiac tamponade', 'MP:0001648', 'abnormal apoptosis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215621, 'HP:0033415', 'Cardiac tamponade', 'MP:0008696', 'increased interleukin-3 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215622, 'HP:0033415', 'Cardiac tamponade', 'MP:0013468', 'chromodacryorrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215623, 'HP:0033415', 'Cardiac tamponade', 'MP:0020039', 'increased bone ossification', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215624, 'HP:0033415', 'Cardiac tamponade', 'MP:0009384', 'cardiac valve regurgitation', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215625, 'HP:0033415', 'Cardiac tamponade', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215626, 'HP:0033415', 'Cardiac tamponade', 'MP:0021022', 'decreased adipose tissue noradrenaline turnover', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215627, 'HP:0033415', 'Cardiac tamponade', 'MP:0020412', 'abnormal amnion physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215628, 'HP:0033415', 'Cardiac tamponade', 'MP:0003216', 'absence seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215629, 'HP:0033415', 'Cardiac tamponade', 'MP:0008776', 'increased right ventricle peak pressure', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215630, 'HP:0033415', 'Cardiac tamponade', 'MP:0001935', 'decreased litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215631, 'HP:0033415', 'Cardiac tamponade', 'MP:0002161', 'abnormal fertility/fecundity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215632, 'HP:0033415', 'Cardiac tamponade', 'MP:0006047', 'aortic valve regurgitation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215633, 'HP:0033415', 'Cardiac tamponade', 'MP:0011831', 'abnormal visual contrast sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215634, 'HP:0033415', 'Cardiac tamponade', 'MP:0031156', 'large intestine hemorrhage', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215635, 'HP:0033415', 'Cardiac tamponade', 'MP:0003868', 'abnormal feces composition', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215636, 'HP:0033415', 'Cardiac tamponade', 'MP:0003259', 'nausea', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215637, 'HP:0033415', 'Cardiac tamponade', 'MP:0004780', 'abnormal surfactant secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215638, 'HP:0033415', 'Cardiac tamponade', 'MP:0002826', 'tonic seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215639, 'HP:0033415', 'Cardiac tamponade', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215640, 'HP:0033415', 'Cardiac tamponade', 'MP:0005085', 'abnormal gallbladder physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215641, 'HP:0033415', 'Cardiac tamponade', 'MP:0002972', 'abnormal cardiac muscle contractility', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215642, 'HP:0033415', 'Cardiac tamponade', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215643, 'HP:0033415', 'Cardiac tamponade', 'MP:0006336', 'abnormal otoacoustic response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215644, 'HP:0033415', 'Cardiac tamponade', 'MP:0031222', 'decreased CXCL10 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215645, 'HP:0033415', 'Cardiac tamponade', 'MP:0004558', 'delayed allantois development', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215646, 'HP:0033415', 'Cardiac tamponade', 'MP:0000503', 'excessive digestive secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215647, 'HP:0033415', 'Cardiac tamponade', 'MP:0014182', 'decreased respiratory epithelial sodium ion transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215648, 'HP:0033415', 'Cardiac tamponade', 'MP:0031152', 'subcutaneous hemorrhage', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215649, 'HP:0033415', 'Cardiac tamponade', 'MP:0001914', 'hemorrhage', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215650, 'HP:0033415', 'Cardiac tamponade', 'MP:0000352', 'decreased cell proliferation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215651, 'HP:0033415', 'Cardiac tamponade', 'MP:0001857', 'pericarditis', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215652, 'HP:0033415', 'Cardiac tamponade', 'MP:0003880', 'abnormal central pattern generator function', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215653, 'HP:0033415', 'Cardiac tamponade', 'MP:0010072', 'increased pruritus', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215654, 'HP:0033415', 'Cardiac tamponade', 'MP:0003412', 'abnormal afterhyperpolarization', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215655, 'HP:0033415', 'Cardiac tamponade', 'MP:0031470', 'abnormal macropinocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215656, 'HP:0033415', 'Cardiac tamponade', 'MP:0003191', 'abnormal cellular cholesterol metabolism', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215657, 'HP:0033415', 'Cardiac tamponade', 'MP:0013625', 'increased femur yield load', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215658, 'HP:0033415', 'Cardiac tamponade', 'MP:0002987', 'abnormal urine osmolality', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215659, 'HP:0033415', 'Cardiac tamponade', 'MP:0014027', 'abnormal respiratory epithelial chloride transmembrane transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215660, 'HP:0033415', 'Cardiac tamponade', 'MP:0008681', 'increased interleukin-17 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215661, 'HP:0033415', 'Cardiac tamponade', 'MP:0005403', 'abnormal nerve conduction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215662, 'HP:0033415', 'Cardiac tamponade', 'MP:0013806', 'encephalopathy', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215663, 'HP:0033415', 'Cardiac tamponade', 'MP:0001952', 'increased airway responsiveness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215664, 'HP:0033415', 'Cardiac tamponade', 'MP:0010634', 'increased QRS amplitude', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215665, 'HP:0033415', 'Cardiac tamponade', 'MP:0002626', 'increased heart rate', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215666, 'HP:0033415', 'Cardiac tamponade', 'MP:0001919', 'abnormal reproductive system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215667, 'HP:0033415', 'Cardiac tamponade', 'MP:0001756', 'abnormal urination', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215668, 'HP:0033415', 'Cardiac tamponade', 'MP:0008563', 'decreased interferon-alpha secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215669, 'HP:0033415', 'Cardiac tamponade', 'MP:0011418', 'leukocyturia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215670, 'HP:0033415', 'Cardiac tamponade', 'MP:0030574', 'increased hair follicle cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215671, 'HP:0033415', 'Cardiac tamponade', 'MP:0002334', 'abnormal airway responsiveness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215672, 'HP:0033415', 'Cardiac tamponade', 'MP:0008002', 'hyperchlorhydria', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215673, 'HP:0033415', 'Cardiac tamponade', 'MP:0010141', 'lymphangitis', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215674, 'HP:0033415', 'Cardiac tamponade', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215675, 'HP:0033415', 'Cardiac tamponade', 'MP:0010071', 'abnormal pruritus', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215676, 'HP:0033415', 'Cardiac tamponade', 'MP:0011953', 'prolonged PQ interval', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215677, 'HP:0033415', 'Cardiac tamponade', 'MP:0005671', 'abnormal response to transplant', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215678, 'HP:0033415', 'Cardiac tamponade', 'MP:0010936', 'decreased airway resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215679, 'HP:0033415', 'Cardiac tamponade', 'MP:0011919', 'abnormal R wave', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215680, 'HP:0033415', 'Cardiac tamponade', 'MP:0003726', 'decreased autoantibody level', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215681, 'HP:0033415', 'Cardiac tamponade', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215682, 'HP:0033415', 'Cardiac tamponade', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215683, 'HP:0033415', 'Cardiac tamponade', 'MP:0003725', 'increased autoantibody level', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215684, 'HP:0033415', 'Cardiac tamponade', 'MP:0000951', 'sporadic seizures', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215685, 'HP:0033415', 'Cardiac tamponade', 'MP:0012032', 'abnormal ERG latency', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215686, 'HP:0033415', 'Cardiac tamponade', 'MP:0001634', 'internal hemorrhage', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215687, 'HP:0033415', 'Cardiac tamponade', 'MP:0002635', 'reduced sensorimotor gating', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215688, 'HP:0033415', 'Cardiac tamponade', 'MP:0006383', 'abnormal cochlear frequency tuning', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215689, 'HP:0033415', 'Cardiac tamponade', 'MP:0013971', 'blood in lymph vessels', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215690, 'HP:0033415', 'Cardiac tamponade', 'MP:0020080', 'increased bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215691, 'HP:0033415', 'Cardiac tamponade', 'MP:0031221', 'abnormal CXCL10 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215692, 'HP:0033415', 'Cardiac tamponade', 'MP:0010393', 'shortened QRS complex duration', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215693, 'HP:0033415', 'Cardiac tamponade', 'MP:0013171', 'ear hemorrhage', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215694, 'HP:0033415', 'Cardiac tamponade', 'MP:0010515', 'abnormal Q wave', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215695, 'HP:0033415', 'Cardiac tamponade', 'MP:0004875', 'increased mean systemic arterial blood pressure', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215696, 'HP:0033415', 'Cardiac tamponade', 'MP:0008673', 'decreased interleukin-13 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215697, 'HP:0033415', 'Cardiac tamponade', 'MP:0002128', 'abnormal blood circulation', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215698, 'HP:0033415', 'Cardiac tamponade', 'MP:0014020', 'intramural bleeding in blood vessel wall', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215699, 'HP:0033415', 'Cardiac tamponade', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215700, 'HP:0033415', 'Cardiac tamponade', 'MP:0002406', 'increased susceptibility to infection', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215701, 'HP:0033415', 'Cardiac tamponade', 'MP:0004070', 'abnormal P wave', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215702, 'HP:0033415', 'Cardiac tamponade', 'MP:0008711', 'increased interleukin-9 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215703, 'HP:0033415', 'Cardiac tamponade', 'MP:0003896', 'prolonged PR interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215704, 'HP:0033415', 'Cardiac tamponade', 'MP:0004879', 'decreased systemic vascular resistance', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215705, 'HP:0033415', 'Cardiac tamponade', 'MP:0013127', 'epistaxis', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215706, 'HP:0033415', 'Cardiac tamponade', 'MP:0021016', 'decreased tau protein phosphorylation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215707, 'HP:0033415', 'Cardiac tamponade', 'MP:0031130', 'right-to-left shunt', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215708, 'HP:0033415', 'Cardiac tamponade', 'MP:0002136', 'abnormal kidney physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215709, 'HP:0033415', 'Cardiac tamponade', 'MP:0010950', 'abnormal lung hysteresivity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215710, 'HP:0033415', 'Cardiac tamponade', 'MP:0001845', 'abnormal inflammatory response', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215711, 'HP:0033415', 'Cardiac tamponade', 'MP:0000343', 'abnormal response to cardiac infarction', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215712, 'HP:0033415', 'Cardiac tamponade', 'MP:0001761', 'abnormal urination pattern', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215713, 'HP:0033415', 'Cardiac tamponade', 'MP:0005402', 'abnormal action potential', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215714, 'HP:0033415', 'Cardiac tamponade', 'MP:0020846', 'abnormal cell motility', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215715, 'HP:0033415', 'Cardiac tamponade', 'MP:0001790', 'abnormal immune system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215716, 'HP:0033415', 'Cardiac tamponade', 'MP:0003468', 'increased single cell response intensity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215717, 'HP:0033415', 'Cardiac tamponade', 'MP:0010073', 'decreased pruritus', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215718, 'HP:0033415', 'Cardiac tamponade', 'MP:0013305', 'isosthenuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215719, 'HP:0033415', 'Cardiac tamponade', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215720, 'HP:0033415', 'Cardiac tamponade', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215721, 'HP:0033415', 'Cardiac tamponade', 'MP:0020096', 'high mean heart rate adaptation', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215722, 'HP:0033415', 'Cardiac tamponade', 'MP:0006110', 'ventricular fibrillation', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215723, 'HP:0033415', 'Cardiac tamponade', 'MP:0003280', 'urinary incontinence', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215724, 'HP:0033415', 'Cardiac tamponade', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215725, 'HP:0033415', 'Cardiac tamponade', 'MP:0004877', 'abnormal systemic vascular resistance', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215726, 'HP:0033415', 'Cardiac tamponade', 'MP:0013559', 'abnormal exocrine gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215727, 'HP:0033415', 'Cardiac tamponade', 'MP:0004050', 'abnormal renal sympathetic nerve activity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215728, 'HP:0033415', 'Cardiac tamponade', 'MP:0002879', 'increased cellular sensitivity to X-ray irradiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215729, 'HP:0033415', 'Cardiac tamponade', 'MP:0014041', 'increased cellular sensitivity to cisplatin', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215730, 'HP:0033415', 'Cardiac tamponade', 'MP:0004217', 'salt-sensitive hypertension', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215731, 'HP:0033415', 'Cardiac tamponade', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215732, 'HP:0033415', 'Cardiac tamponade', 'MP:0013642', 'decreased vertebra stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215733, 'HP:0033415', 'Cardiac tamponade', 'MP:0031170', 'abnormal vasculature physiology', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215734, 'HP:0033415', 'Cardiac tamponade', 'MP:0003878', 'abnormal ear physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215735, 'HP:0033415', 'Cardiac tamponade', 'MP:0003659', 'abnormal lymph circulation', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215736, 'HP:0033415', 'Cardiac tamponade', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215737, 'HP:0033415', 'Cardiac tamponade', 'MP:0013557', 'abnormal merocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215738, 'HP:0033415', 'Cardiac tamponade', 'MP:0011421', 'cylindruria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215739, 'HP:0033415', 'Cardiac tamponade', 'MP:0001912', 'increased cerebrospinal fluid production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215740, 'HP:0033415', 'Cardiac tamponade', 'MP:0004010', 'increased diastolic filling velocity', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215741, 'HP:0033415', 'Cardiac tamponade', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215742, 'HP:0033415', 'Cardiac tamponade', 'MP:0001727', 'abnormal embryo implantation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215743, 'HP:0033415', 'Cardiac tamponade', 'MP:0002694', 'abnormal pancreas secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215744, 'HP:0033415', 'Cardiac tamponade', 'MP:0005501', 'abnormal skin physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215745, 'HP:0033415', 'Cardiac tamponade', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215746, 'HP:0033415', 'Cardiac tamponade', 'MP:0005529', 'abnormal renal vascular resistance', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215747, 'HP:0033415', 'Cardiac tamponade', 'MP:0002419', 'abnormal innate immunity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215748, 'HP:0033415', 'Cardiac tamponade', 'MP:0000350', 'abnormal cell proliferation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215749, 'HP:0033415', 'Cardiac tamponade', 'MP:0001627', 'abnormal cardiac output', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215750, 'HP:0033415', 'Cardiac tamponade', 'MP:0003233', 'prolonged QT interval', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215751, 'HP:0033415', 'Cardiac tamponade', 'MP:0011809', 'abnormal anoikis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215752, 'HP:0033415', 'Cardiac tamponade', 'MP:0009275', 'bruising', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215753, 'HP:0033415', 'Cardiac tamponade', 'MP:0004216', 'salt-resistant hypertension', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215754, 'HP:0033415', 'Cardiac tamponade', 'MP:0010516', 'absent Q wave', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215755, 'HP:0033415', 'Cardiac tamponade', 'MP:0010946', 'hyperpnea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215756, 'HP:0033415', 'Cardiac tamponade', 'MP:0010758', 'increased right ventricle systolic pressure', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215757, 'HP:0033415', 'Cardiac tamponade', 'MP:0006138', 'congestive heart failure', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215758, 'HP:0033415', 'Cardiac tamponade', 'MP:0013285', 'abnormal renal filtration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215759, 'HP:0033415', 'Cardiac tamponade', 'MP:0020002', 'increased response to antigen', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215760, 'HP:0033415', 'Cardiac tamponade', 'MP:0003261', 'hematemesis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215761, 'HP:0033415', 'Cardiac tamponade', 'MP:0030904', 'abnormal melanoblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215762, 'HP:0033415', 'Cardiac tamponade', 'MP:0003741', 'tinnitus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215763, 'HP:0033415', 'Cardiac tamponade', 'MP:0011926', 'abnormal heart valve physiology', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215764, 'HP:0033415', 'Cardiac tamponade', 'MP:0013636', 'abnormal bone stiffness', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215765, 'HP:0033415', 'Cardiac tamponade', 'MP:0005435', 'hemoperitoneum', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215766, 'HP:0033415', 'Cardiac tamponade', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215767, 'HP:0033415', 'Cardiac tamponade', 'MP:0031014', 'polyspermy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215768, 'HP:0033415', 'Cardiac tamponade', 'MP:0003038', 'decreased myocardial infarct size', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215769, 'HP:0033415', 'Cardiac tamponade', 'MP:0005575', 'increased pulmonary ventilation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215770, 'HP:0033415', 'Cardiac tamponade', 'MP:0003480', 'increased nerve fiber response intensity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215771, 'HP:0033415', 'Cardiac tamponade', 'MP:0002634', 'abnormal sensorimotor gating', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215772, 'HP:0033415', 'Cardiac tamponade', 'MP:0010368', 'abnormal lymphatic system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215773, 'HP:0033415', 'Cardiac tamponade', 'MP:0003096', 'increased corneal light-scattering', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215774, 'HP:0033415', 'Cardiac tamponade', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215775, 'HP:0033415', 'Cardiac tamponade', 'MP:0002133', 'abnormal respiratory system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215776, 'HP:0033415', 'Cardiac tamponade', 'MP:0031402', 'decreased muscle fatigability', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215777, 'HP:0033415', 'Cardiac tamponade', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215778, 'HP:0033415', 'Cardiac tamponade', 'MP:0010334', 'pleural effusion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215779, 'HP:0033415', 'Cardiac tamponade', 'MP:0030951', 'abnormal endocytosis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215780, 'HP:0033415', 'Cardiac tamponade', 'MP:0010992', 'increased surfactant secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215781, 'HP:0033415', 'Cardiac tamponade', 'MP:0031088', 'coughing', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215782, 'HP:0033415', 'Cardiac tamponade', 'MP:0010377', 'abnormal gut flora balance', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215783, 'HP:0033415', 'Cardiac tamponade', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215784, 'HP:0033415', 'Cardiac tamponade', 'MP:0011758', 'renal ischemia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215785, 'HP:0033415', 'Cardiac tamponade', 'MP:0012382', 'abnormal blood cell physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215786, 'HP:0033415', 'Cardiac tamponade', 'MP:0031424', 'enhanced female fertility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215787, 'HP:0033415', 'Cardiac tamponade', 'MP:0001596', 'hypotension', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215788, 'HP:0033415', 'Cardiac tamponade', 'MP:0001933', 'abnormal litter size', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215789, 'HP:0033415', 'Cardiac tamponade', 'MP:0010520', 'sinoatrial block', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215790, 'HP:0033415', 'Cardiac tamponade', 'MP:0008682', 'decreased interleukin-17 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215791, 'HP:0033415', 'Cardiac tamponade', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215792, 'HP:0033415', 'Cardiac tamponade', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215793, 'HP:0033415', 'Cardiac tamponade', 'MP:0001619', 'abnormal vascular permeability', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215794, 'HP:0033415', 'Cardiac tamponade', 'MP:0001337', 'dry eyes', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215795, 'HP:0033415', 'Cardiac tamponade', 'MP:0003865', 'lymph node inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215796, 'HP:0033415', 'Cardiac tamponade', 'MP:0008722', 'abnormal chemokine secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215797, 'HP:0033415', 'Cardiac tamponade', 'MP:0001864', 'vascular inflammation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215798, 'HP:0033415', 'Cardiac tamponade', 'MP:0003899', 'abnormal QT interval', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215799, 'HP:0033415', 'Cardiac tamponade', 'MP:0008708', 'increased interleukin-7 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215800, 'HP:0033415', 'Cardiac tamponade', 'MP:0001613', 'abnormal vasodilation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215801, 'HP:0033415', 'Cardiac tamponade', 'MP:0002842', 'increased systemic arterial blood pressure', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215802, 'HP:0033415', 'Cardiac tamponade', 'MP:0030975', 'placenta hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215803, 'HP:0033415', 'Cardiac tamponade', 'MP:0003483', 'decreased nerve fiber response threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215804, 'HP:0033415', 'Cardiac tamponade', 'MP:0012120', 'trophectoderm cell degeneration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215805, 'HP:0033415', 'Cardiac tamponade', 'MP:0001599', 'abnormal blood volume', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215806, 'HP:0033415', 'Cardiac tamponade', 'MP:0006335', 'abnormal hearing electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215807, 'HP:0033415', 'Cardiac tamponade', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215808, 'HP:0033415', 'Cardiac tamponade', 'MP:0014042', 'decreased cellular sensitivity to DNA damaging agents', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215809, 'HP:0033415', 'Cardiac tamponade', 'MP:0005410', 'abnormal fertilization', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215810, 'HP:0033415', 'Cardiac tamponade', 'MP:0014028', 'decreased respiratory epithelial chloride transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215811, 'HP:0033415', 'Cardiac tamponade', 'MP:0009668', 'ectopic pregnancy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215812, 'HP:0033415', 'Cardiac tamponade', 'MP:0003471', 'abnormal summary potential threshold', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215813, 'HP:0033415', 'Cardiac tamponade', 'MP:0003009', 'abnormal cytokine secretion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215814, 'HP:0033415', 'Cardiac tamponade', 'MP:0008669', 'increased interleukin-12b secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215815, 'HP:0033415', 'Cardiac tamponade', 'MP:0008775', 'abnormal heart ventricle pressure', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215816, 'HP:0033415', 'Cardiac tamponade', 'MP:0003996', 'clonic seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215817, 'HP:0033415', 'Cardiac tamponade', 'MP:0000743', 'muscle spasm', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215818, 'HP:0033415', 'Cardiac tamponade', 'MP:0002693', 'abnormal pancreas physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215819, 'HP:0033415', 'Cardiac tamponade', 'MP:0010507', 'shortened RR interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215820, 'HP:0033415', 'Cardiac tamponade', 'MP:0014046', 'abnormal mitophagy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215821, 'HP:0033415', 'Cardiac tamponade', 'MP:0001945', 'bronchoconstriction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215822, 'HP:0033415', 'Cardiac tamponade', 'MP:0009698', 'heart hemorrhage', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215823, 'HP:0033415', 'Cardiac tamponade', 'MP:0001664', 'abnormal digestion', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215824, 'HP:0033415', 'Cardiac tamponade', 'MP:0003100', 'myopia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215825, 'HP:0033415', 'Cardiac tamponade', 'MP:0005001', 'abnormal clonal deletion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215826, 'HP:0033415', 'Cardiac tamponade', 'MP:0020142', 'increased anti-sperm antibody level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215827, 'HP:0033415', 'Cardiac tamponade', 'MP:0005076', 'abnormal cell differentiation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215828, 'HP:0033415', 'Cardiac tamponade', 'MP:0020040', 'decreased bone ossification', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215829, 'HP:0033415', 'Cardiac tamponade', 'MP:0011718', 'decreased interleukin-8 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215830, 'HP:0033415', 'Cardiac tamponade', 'MP:0002064', 'seizures', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215831, 'HP:0033415', 'Cardiac tamponade', 'MP:0011082', 'abnormal gastrointestinal motility', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215832, 'HP:0033415', 'Cardiac tamponade', 'MP:0001856', 'myocarditis', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215833, 'HP:0033415', 'Cardiac tamponade', 'MP:0009057', 'increased interleukin-21 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215834, 'HP:0033415', 'Cardiac tamponade', 'MP:0000233', 'abnormal blood flow velocity', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215835, 'HP:0033415', 'Cardiac tamponade', 'MP:0011925', 'abnormal heart echocardiography feature', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215836, 'HP:0033415', 'Cardiac tamponade', 'MP:0014043', 'decreased cellular sensitivity to cisplatin', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215837, 'HP:0033415', 'Cardiac tamponade', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215838, 'HP:0033415', 'Cardiac tamponade', 'MP:0004005', 'impaired contractility of intestinal smooth muscle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215839, 'HP:0033415', 'Cardiac tamponade', 'MP:0008001', 'hypochlorhydria', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215840, 'HP:0033415', 'Cardiac tamponade', 'MP:0003089', 'decreased skin tensile strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215841, 'HP:0033415', 'Cardiac tamponade', 'MP:0010935', 'increased airway resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215842, 'HP:0033415', 'Cardiac tamponade', 'MP:0014030', 'abnormal mucous gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215843, 'HP:0033415', 'Cardiac tamponade', 'MP:0012029', 'abnormal electroretinogram waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215844, 'HP:0033415', 'Cardiac tamponade', 'MP:0005004', 'abnormal lymphocyte anergy', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215845, 'HP:0033415', 'Cardiac tamponade', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215846, 'HP:0033415', 'Cardiac tamponade', 'MP:0002325', 'abnormal pulmonary diffusing capacity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215847, 'HP:0033415', 'Cardiac tamponade', 'MP:0004036', 'abnormal muscle relaxation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215848, 'HP:0033415', 'Cardiac tamponade', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215849, 'HP:0033415', 'Cardiac tamponade', 'MP:0030619', 'homogentisic aciduria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215850, 'HP:0033415', 'Cardiac tamponade', 'MP:0011420', 'pyuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215851, 'HP:0033415', 'Cardiac tamponade', 'MP:0012045', 'increased susceptibility to hypertension', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215852, 'HP:0033415', 'Cardiac tamponade', 'MP:0012200', 'increased endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215853, 'HP:0033415', 'Cardiac tamponade', 'MP:0008814', 'decreased nerve conduction velocity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215854, 'HP:0033415', 'Cardiac tamponade', 'MP:0011047', 'increased lung tissue damping', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215855, 'HP:0033415', 'Cardiac tamponade', 'MP:0003467', 'abnormal single cell response intensity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215856, 'HP:0033415', 'Cardiac tamponade', 'MP:0006266', 'decreased pulse pressure', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215857, 'HP:0033415', 'Cardiac tamponade', 'MP:0004212', 'abnormal salty taste sensitivity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215858, 'HP:0033415', 'Cardiac tamponade', 'MP:0008700', 'decreased interleukin-4 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215859, 'HP:0033415', 'Cardiac tamponade', 'MP:0002998', 'abnormal bone remodeling', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215860, 'HP:0033415', 'Cardiac tamponade', 'MP:0002164', 'abnormal gland physiology', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215861, 'HP:0033415', 'Cardiac tamponade', 'MP:0030215', 'facial muscle fasciculation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215862, 'HP:0033415', 'Cardiac tamponade', 'MP:0004037', 'increased muscle relaxation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215863, 'HP:0033415', 'Cardiac tamponade', 'MP:0004012', 'increased pulmonary artery pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215864, 'HP:0033415', 'Cardiac tamponade', 'MP:0011044', 'increased lung elastance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215865, 'HP:0033415', 'Cardiac tamponade', 'MP:0030573', 'abnormal hair follicle cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215866, 'HP:0033415', 'Cardiac tamponade', 'MP:0010519', 'atrioventricular block', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215867, 'HP:0033415', 'Cardiac tamponade', 'MP:0001598', 'abnormal blood viscosity', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215868, 'HP:0033415', 'Cardiac tamponade', 'MP:0011045', 'decreased lung elastance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215869, 'HP:0033415', 'Cardiac tamponade', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215870, 'HP:0033415', 'Cardiac tamponade', 'MP:0003897', 'abnormal ST segment', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215871, 'HP:0033415', 'Cardiac tamponade', 'MP:0001835', 'abnormal antigen presentation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215872, 'HP:0033415', 'Cardiac tamponade', 'MP:0009348', 'abnormal urine pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215873, 'HP:0033415', 'Cardiac tamponade', 'MP:0005532', 'abnormal vascular resistance', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215874, 'HP:0033415', 'Cardiac tamponade', 'MP:0008562', 'increased interferon-alpha secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215875, 'HP:0033415', 'Cardiac tamponade', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215876, 'HP:0033415', 'Cardiac tamponade', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215877, 'HP:0033415', 'Cardiac tamponade', 'MP:0009567', 'mitotic nondisjunction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215878, 'HP:0033415', 'Cardiac tamponade', 'MP:0013561', 'abnormal endocrine gland physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215879, 'HP:0033415', 'Cardiac tamponade', 'MP:0000351', 'increased cell proliferation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215880, 'HP:0033415', 'Cardiac tamponade', 'MP:0031086', 'wheezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215881, 'HP:0033415', 'Cardiac tamponade', 'MP:0008703', 'decreased interleukin-5 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215882, 'HP:0033415', 'Cardiac tamponade', 'MP:0002327', 'abnormal respiratory function', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215883, 'HP:0033415', 'Cardiac tamponade', 'MP:0003116', 'rickets', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215884, 'HP:0033415', 'Cardiac tamponade', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215885, 'HP:0033415', 'Cardiac tamponade', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215886, 'HP:0033415', 'Cardiac tamponade', 'MP:0021009', 'abnormal synaptic physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215887, 'HP:0033415', 'Cardiac tamponade', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215888, 'HP:0033415', 'Cardiac tamponade', 'MP:0031217', 'increased susceptibility to myocardial ischemic injury', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215889, 'HP:0033415', 'Cardiac tamponade', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215890, 'HP:0033415', 'Cardiac tamponade', 'MP:0001665', 'chronic diarrhea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215891, 'HP:0033415', 'Cardiac tamponade', 'MP:0003926', 'decreased cellular glucose uptake', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215892, 'HP:0033415', 'Cardiac tamponade', 'MP:0020845', 'abnormal DNA-templated transcription', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215893, 'HP:0033415', 'Cardiac tamponade', 'MP:0011929', 'abnormal aortic valve flow', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215894, 'HP:0033415', 'Cardiac tamponade', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215895, 'HP:0033415', 'Cardiac tamponade', 'MP:0008652', 'decreased interleukin-1 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215896, 'HP:0033415', 'Cardiac tamponade', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215897, 'HP:0033415', 'Cardiac tamponade', 'MP:0004086', 'absent heartbeat', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215898, 'HP:0033415', 'Cardiac tamponade', 'MP:0005037', 'mucous diarrhea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215899, 'HP:0033415', 'Cardiac tamponade', 'MP:0006002', 'abnormal small intestinal transit time', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215900, 'HP:0033415', 'Cardiac tamponade', 'MP:0006143', 'increased systemic arterial diastolic blood pressure', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215901, 'HP:0033415', 'Cardiac tamponade', 'MP:0012565', 'perivasculitis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215902, 'HP:0033415', 'Cardiac tamponade', 'MP:0021023', 'increased adipose tissue noradrenaline turnover', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215903, 'HP:0033415', 'Cardiac tamponade', 'MP:0010993', 'decreased surfactant secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215904, 'HP:0033415', 'Cardiac tamponade', 'MP:0004122', 'abnormal sinus arrhythmia', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215905, 'HP:0033415', 'Cardiac tamponade', 'MP:0003091', 'abnormal cell migration', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215906, 'HP:0033415', 'Cardiac tamponade', 'MP:0004587', 'decreased cellular sensitivity to X-ray irradiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215907, 'HP:0033415', 'Cardiac tamponade', 'MP:0006080', 'brain ischemia', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215908, 'HP:0033415', 'Cardiac tamponade', 'MP:0001917', 'intraventricular hemorrhage', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215909, 'HP:0033415', 'Cardiac tamponade', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215910, 'HP:0033415', 'Cardiac tamponade', 'MP:0014274', 'decreased respiration', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215911, 'HP:0033415', 'Cardiac tamponade', 'MP:0008004', 'abnormal stomach pH', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215912, 'HP:0033415', 'Cardiac tamponade', 'MP:0010571', 'shortened ST segment', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215913, 'HP:0033415', 'Cardiac tamponade', 'MP:0031118', 'cardiovalvulitis', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215914, 'HP:0033415', 'Cardiac tamponade', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215915, 'HP:0033415', 'Cardiac tamponade', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215916, 'HP:0033415', 'Cardiac tamponade', 'MP:0005599', 'increased cardiac muscle contractility', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215917, 'HP:0033415', 'Cardiac tamponade', 'MP:0008566', 'increased interferon-gamma secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215918, 'HP:0033415', 'Cardiac tamponade', 'MP:0000740', 'impaired smooth muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215919, 'HP:0033415', 'Cardiac tamponade', 'MP:0008685', 'decreased interleukin-18 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215920, 'HP:0033415', 'Cardiac tamponade', 'MP:0008411', 'decreased cellular sensitivity to ultraviolet irradiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215921, 'HP:0033415', 'Cardiac tamponade', 'MP:0011467', 'decreased urine urea nitrogen level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215922, 'HP:0033415', 'Cardiac tamponade', 'MP:0003472', 'increased summary potential threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215923, 'HP:0033415', 'Cardiac tamponade', 'MP:0006043', 'decreased apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215924, 'HP:0033415', 'Cardiac tamponade', 'MP:0010559', 'heart block', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215925, 'HP:0033415', 'Cardiac tamponade', 'MP:0004878', 'increased systemic vascular resistance', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215926, 'HP:0033415', 'Cardiac tamponade', 'MP:0008712', 'decreased interleukin-9 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215927, 'HP:0033415', 'Cardiac tamponade', 'MP:0003256', 'biliary cirrhosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215928, 'HP:0033415', 'Cardiac tamponade', 'MP:0000947', 'convulsive seizures', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215929, 'HP:0033415', 'Cardiac tamponade', 'MP:0003762', 'abnormal immune organ physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215930, 'HP:0033415', 'Cardiac tamponade', 'MP:0012124', 'increased bronchoconstrictive response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215931, 'HP:0033415', 'Cardiac tamponade', 'MP:0003882', 'abnormal pulse pressure', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215932, 'HP:0033415', 'Cardiac tamponade', 'MP:0010695', 'abnormal blood pressure regulation', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215933, 'HP:0033415', 'Cardiac tamponade', 'MP:0003777', 'lip inflammation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215934, 'HP:0033415', 'Cardiac tamponade', 'MP:0001629', 'abnormal heart rate', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215935, 'HP:0033415', 'Cardiac tamponade', 'MP:0030129', 'tongue inflammation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215936, 'HP:0033415', 'Cardiac tamponade', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215937, 'HP:0033415', 'Cardiac tamponade', 'MP:0008555', 'abnormal interferon secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215938, 'HP:0033415', 'Cardiac tamponade', 'MP:0011930', 'abnormal tricuspid valve flow', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215939, 'HP:0033415', 'Cardiac tamponade', 'MP:0004046', 'abnormal mitosis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215940, 'HP:0033415', 'Cardiac tamponade', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215941, 'HP:0033415', 'Cardiac tamponade', 'MP:0031091', 'hypogeusia', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215942, 'HP:0033415', 'Cardiac tamponade', 'MP:0003621', 'dysuria', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215943, 'HP:0033415', 'Cardiac tamponade', 'MP:0008943', 'increased sensitivity to induced cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215944, 'HP:0033415', 'Cardiac tamponade', 'MP:0008564', 'increased interferon-beta secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215945, 'HP:0033415', 'Cardiac tamponade', 'MP:0031154', 'intestinal hemorrhage', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215946, 'HP:0033415', 'Cardiac tamponade', 'MP:0008009', 'delayed cellular replicative senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215947, 'HP:0033415', 'Cardiac tamponade', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215948, 'HP:0033415', 'Cardiac tamponade', 'MP:0006109', 'fibrillation', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215949, 'HP:0033415', 'Cardiac tamponade', 'MP:0001943', 'abnormal respiration', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215950, 'HP:0033415', 'Cardiac tamponade', 'MP:0001819', 'abnormal immune cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215951, 'HP:0033415', 'Cardiac tamponade', 'MP:0006054', 'spinal hemorrhage', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215952, 'HP:0033415', 'Cardiac tamponade', 'MP:0011824', 'increased cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215953, 'HP:0033415', 'Cardiac tamponade', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215954, 'HP:0033415', 'Cardiac tamponade', 'MP:0009350', 'decreased urine pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215955, 'HP:0033415', 'Cardiac tamponade', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215956, 'HP:0033415', 'Cardiac tamponade', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215957, 'HP:0033415', 'Cardiac tamponade', 'MP:0012555', 'decreased cell death', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215958, 'HP:0033415', 'Cardiac tamponade', 'MP:0001663', 'abnormal digestive system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215959, 'HP:0033415', 'Cardiac tamponade', 'MP:0031127', 'dry gangrene', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215960, 'HP:0033415', 'Cardiac tamponade', 'MP:0001793', 'abnormal susceptibility to infection', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215961, 'HP:0033415', 'Cardiac tamponade', 'MP:0002421', 'abnormal cell-mediated immunity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215962, 'HP:0033415', 'Cardiac tamponade', 'MP:0008688', 'decreased interleukin-2 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215963, 'HP:0033415', 'Cardiac tamponade', 'MP:0013641', 'increased vertebra stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215964, 'HP:0033415', 'Cardiac tamponade', 'MP:0004766', 'decreased susceptibility to age-related hearing loss', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215965, 'HP:0033415', 'Cardiac tamponade', 'MP:0008663', 'increased interleukin-12 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215966, 'HP:0033415', 'Cardiac tamponade', 'MP:0013752', 'stridor', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215967, 'HP:0033415', 'Cardiac tamponade', 'MP:0002409', 'decreased susceptibility to infection', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215968, 'HP:0033415', 'Cardiac tamponade', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215969, 'HP:0033415', 'Cardiac tamponade', 'MP:0004244', 'abnormal miscarriage rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215970, 'HP:0033415', 'Cardiac tamponade', 'MP:0003633', 'abnormal nervous system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215971, 'HP:0033415', 'Cardiac tamponade', 'MP:0010994', 'aerophagia', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215972, 'HP:0033415', 'Cardiac tamponade', 'MP:0010553', 'prolonged HV interval', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215973, 'HP:0033415', 'Cardiac tamponade', 'MP:0030214', 'muscle fasciculation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215974, 'HP:0033415', 'Cardiac tamponade', 'MP:0006003', 'abnormal large intestinal transit time', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215975, 'HP:0033415', 'Cardiac tamponade', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215976, 'HP:0033415', 'Cardiac tamponade', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215977, 'HP:0033415', 'Cardiac tamponade', 'MP:0003698', 'abnormal male reproductive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215978, 'HP:0033415', 'Cardiac tamponade', 'MP:0010155', 'abnormal intestine physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215979, 'HP:0033415', 'Cardiac tamponade', 'MP:0031385', 'enhanced blood-brain barrier function', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215980, 'HP:0033415', 'Cardiac tamponade', 'MP:0005621', 'abnormal cell physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215981, 'HP:0033415', 'Cardiac tamponade', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215982, 'HP:0033415', 'Cardiac tamponade', 'MP:0008691', 'decreased interleukin-23 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215983, 'HP:0033415', 'Cardiac tamponade', 'MP:0004215', 'abnormal myocardial fiber physiology', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215984, 'HP:0033415', 'Cardiac tamponade', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215985, 'HP:0033415', 'Cardiac tamponade', 'MP:0012553', 'decreased serum complement activity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215986, 'HP:0033415', 'Cardiac tamponade', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215987, 'HP:0033415', 'Cardiac tamponade', 'MP:0011295', 'abnormal tubuloglomerular feedback response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215988, 'HP:0033415', 'Cardiac tamponade', 'MP:0009661', 'abnormal pregnancy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215989, 'HP:0033415', 'Cardiac tamponade', 'MP:0001378', 'abnormal ejaculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215990, 'HP:0033415', 'Cardiac tamponade', 'MP:0008403', 'decreased cellular sensitivity to alkylating agents', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215991, 'HP:0033415', 'Cardiac tamponade', 'MP:0001837', 'defective assembly of class I molecules', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215992, 'HP:0033415', 'Cardiac tamponade', 'MP:0014201', 'abnormal intestinal epithelium physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215993, 'HP:0033415', 'Cardiac tamponade', 'MP:0011936', 'abnormal PP interval', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215994, 'HP:0033415', 'Cardiac tamponade', 'MP:0002338', 'abnormal pulmonary ventilation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215995, 'HP:0033415', 'Cardiac tamponade', 'MP:0002988', 'decreased urine osmolality', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215996, 'HP:0033415', 'Cardiac tamponade', 'MP:0000738', 'impaired muscle contractility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215997, 'HP:0033415', 'Cardiac tamponade', 'MP:0010505', 'abnormal T wave', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(215998, 'HP:0033415', 'Cardiac tamponade', 'MP:0008697', 'decreased interleukin-3 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(215999, 'HP:0033415', 'Cardiac tamponade', 'MP:0011804', 'increased cell migration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216000, 'HP:0033415', 'Cardiac tamponade', 'MP:0011918', 'abnormal PQ interval', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(216001, 'HP:0033415', 'Cardiac tamponade', 'MP:0010509', 'decreased P wave amplitude', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(216002, 'HP:0033415', 'Cardiac tamponade', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216003, 'HP:0033415', 'Cardiac tamponade', 'MP:0000427', 'abnormal hair cycle', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216004, 'HP:0033415', 'Cardiac tamponade', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216005, 'HP:0033415', 'Cardiac tamponade', 'MP:0002328', 'abnormal airway resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216006, 'HP:0033415', 'Cardiac tamponade', 'MP:0031192', 'coronary artery spasm', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(216007, 'HP:0033415', 'Cardiac tamponade', 'MP:0020439', 'absent b-wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216008, 'HP:0033415', 'Cardiac tamponade', 'MP:0003466', 'decreased single cell response threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216009, 'HP:0033415', 'Cardiac tamponade', 'MP:0008651', 'increased interleukin-1 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216010, 'HP:0033415', 'Cardiac tamponade', 'MP:0011514', 'skin hemorrhage', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(216011, 'HP:0033415', 'Cardiac tamponade', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216012, 'HP:0033415', 'Cardiac tamponade', 'MP:0011931', 'abnormal pulmonary valve flow', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(216013, 'HP:0033415', 'Cardiac tamponade', 'MP:0001844', 'autoimmune response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216014, 'HP:0033415', 'Cardiac tamponade', 'MP:0002296', 'aspiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216015, 'HP:0033415', 'Cardiac tamponade', 'MP:0010954', 'abnormal cellular respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216016, 'HP:0033415', 'Cardiac tamponade', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(216017, 'HP:0033415', 'Cardiac tamponade', 'MP:0003476', 'decreased summary potential intensity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216018, 'HP:0033415', 'Cardiac tamponade', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216019, 'HP:0033415', 'Cardiac tamponade', 'MP:0006048', 'pulmonary valve regurgitation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(216020, 'HP:0033415', 'Cardiac tamponade', 'MP:0010506', 'prolonged RR interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(216021, 'HP:0033415', 'Cardiac tamponade', 'MP:0014157', 'alacrima', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216022, 'HP:0033415', 'Cardiac tamponade', 'MP:0011952', 'decreased cardiac stroke volume', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(216023, 'HP:0033415', 'Cardiac tamponade', 'MP:0011951', 'increased cardiac stroke volume', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(216024, 'HP:0033415', 'Cardiac tamponade', 'MP:0002471', 'abnormal complement pathway', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216025, 'HP:0033415', 'Cardiac tamponade', 'MP:0003927', 'increased cellular glucose import', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216026, 'HP:0033415', 'Cardiac tamponade', 'MP:0013555', 'abnormal apocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216027, 'HP:0033415', 'Cardiac tamponade', 'MP:0008690', 'increased interleukin-23 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216028, 'HP:0033415', 'Cardiac tamponade', 'MP:0012685', 'abnormal primitive streak elongation', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216029, 'HP:0033415', 'Cardiac tamponade', 'MP:0002999', 'abnormal bone healing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216030, 'HP:0033415', 'Cardiac tamponade', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(216031, 'HP:0033415', 'Cardiac tamponade', 'MP:0030933', 'hyphema', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(216032, 'HP:0033415', 'Cardiac tamponade', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(216033, 'HP:0033415', 'Cardiac tamponade', 'MP:0003482', 'increased nerve fiber response threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216034, 'HP:0033415', 'Cardiac tamponade', 'MP:0011220', 'increased intestinal calcium absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216035, 'HP:0033415', 'Cardiac tamponade', 'MP:0003252', 'abnormal bile duct physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216036, 'HP:0033415', 'Cardiac tamponade', 'MP:0031124', 'aortic valve inflammation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(216037, 'HP:0033415', 'Cardiac tamponade', 'MP:0001951', 'abnormal breathing pattern', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216038, 'HP:0033415', 'Cardiac tamponade', 'MP:0008709', 'decreased interleukin-7 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216039, 'HP:0033415', 'Cardiac tamponade', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216040, 'HP:0033415', 'Cardiac tamponade', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216041, 'HP:0033415', 'Cardiac tamponade', 'MP:0001948', 'vesicoureteral reflux', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216042, 'HP:0033415', 'Cardiac tamponade', 'MP:0002007', 'increased cellular sensitivity to gamma-irradiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216043, 'HP:0033415', 'Cardiac tamponade', 'MP:0031481', 'decreased urine xanthine level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216044, 'HP:0033415', 'Cardiac tamponade', 'MP:0010394', 'decreased QRS amplitude', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(216045, 'HP:0033415', 'Cardiac tamponade', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216046, 'HP:0033415', 'Cardiac tamponade', 'MP:0003699', 'abnormal female reproductive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216047, 'HP:0033415', 'Cardiac tamponade', 'MP:0008544', 'impaired olfaction', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216048, 'HP:0033415', 'Cardiac tamponade', 'MP:0005088', 'increased acute inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216049, 'HP:0033415', 'Cardiac tamponade', 'MP:0031471', 'abnormal micropinocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216050, 'HP:0033415', 'Cardiac tamponade', 'MP:0010107', 'abnormal renal reabsorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216051, 'HP:0033415', 'Cardiac tamponade', 'MP:0004156', 'abnormal QT variability', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(216052, 'HP:0033415', 'Cardiac tamponade', 'MP:0006114', 'cardiac murmur', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(216053, 'HP:0033415', 'Cardiac tamponade', 'MP:0013639', 'decreased bone stiffness', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216054, 'HP:0033415', 'Cardiac tamponade', 'MP:0010636', 'bundle branch block', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(216055, 'HP:0033415', 'Cardiac tamponade', 'MP:0002420', 'abnormal adaptive immunity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216056, 'HP:0033415', 'Cardiac tamponade', 'MP:0004013', 'decreased pulmonary artery pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(216057, 'HP:0033415', 'Cardiac tamponade', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216058, 'HP:0033415', 'Cardiac tamponade', 'MP:0013644', 'increased vertebra maximal load', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216059, 'HP:0033415', 'Cardiac tamponade', 'MP:0031129', 'left-to-right shunt', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(216060, 'HP:0033415', 'Cardiac tamponade', 'MP:0011466', 'increased urine urea nitrogen level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216061, 'HP:0033415', 'Cardiac tamponade', 'MP:0008684', 'increased interleukin-18 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216062, 'HP:0033415', 'Cardiac tamponade', 'MP:0031098', 'abnormal sputum production', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216063, 'HP:0033415', 'Cardiac tamponade', 'MP:0006046', 'atrioventricular valve regurgitation', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(216064, 'HP:0033415', 'Cardiac tamponade', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216065, 'HP:0033415', 'Cardiac tamponade', 'MP:0001954', 'respiratory distress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216066, 'HP:0033415', 'Cardiac tamponade', 'MP:0003122', 'maternal imprinting', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216067, 'HP:0033415', 'Cardiac tamponade', 'MP:0010094', 'abnormal chromosome stability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216068, 'HP:0033415', 'Cardiac tamponade', 'MP:0003157', 'impaired muscle relaxation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216069, 'HP:0033415', 'Cardiac tamponade', 'MP:0009062', 'impaired lectin complement pathway', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216070, 'HP:0033415', 'Cardiac tamponade', 'MP:0012006', 'abnormal hippocampus physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216071, 'HP:0033415', 'Cardiac tamponade', 'MP:0008567', 'decreased interferon-gamma secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216072, 'HP:0033415', 'Cardiac tamponade', 'MP:0002498', 'abnormal acute inflammation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216073, 'HP:0033415', 'Cardiac tamponade', 'MP:0014181', 'abnormal respiratory epithelial sodium ion transmembrane transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216074, 'HP:0033415', 'Cardiac tamponade', 'MP:0008861', 'abnormal hair shedding', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216075, 'HP:0033415', 'Cardiac tamponade', 'MP:0001542', 'abnormal bone strength', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216076, 'HP:0033415', 'Cardiac tamponade', 'MP:0020974', 'abnormal FO-wave shape', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216077, 'HP:0033415', 'Cardiac tamponade', 'MP:0020347', 'abnormal myocardial fiber sodium currents', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(216078, 'HP:0033415', 'Cardiac tamponade', 'MP:0011920', 'abnormal S wave', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(216079, 'HP:0033415', 'Cardiac tamponade', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(216080, 'HP:0033415', 'Cardiac tamponade', 'MP:0009645', 'crystalluria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216081, 'HP:0033415', 'Cardiac tamponade', 'MP:0009247', 'meteorism', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216082, 'HP:0033415', 'Cardiac tamponade', 'MP:0011518', 'abnormal cell chemotaxis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216083, 'HP:0033415', 'Cardiac tamponade', 'MP:0021015', 'increased tau protein phosphorylation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216084, 'HP:0033415', 'Cardiac tamponade', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216085, 'HP:0033415', 'Cardiac tamponade', 'MP:0030940', 'impaired autophagy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216086, 'HP:0033415', 'Cardiac tamponade', 'MP:0003292', 'melena', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216087, 'HP:0033415', 'Cardiac tamponade', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216088, 'HP:0033415', 'Cardiac tamponade', 'MP:0011432', 'decreased urine flow rate', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216089, 'HP:0033415', 'Cardiac tamponade', 'MP:0000501', 'abnormal digestive secretion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216090, 'HP:0033415', 'Cardiac tamponade', 'MP:0011937', 'shortened PP interval', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(216091, 'HP:0033415', 'Cardiac tamponade', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216092, 'HP:0033415', 'Cardiac tamponade', 'MP:0021053', 'abnormal renal arterial blood pressure', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(216093, 'HP:0033415', 'Cardiac tamponade', 'MP:0003298', 'choking', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216094, 'HP:0033415', 'Cardiac tamponade', 'MP:0010512', 'absent PR interval', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(216095, 'HP:0033415', 'Cardiac tamponade', 'MP:0005253', 'abnormal eye physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216096, 'HP:0033415', 'Cardiac tamponade', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216097, 'HP:0033415', 'Cardiac tamponade', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216098, 'HP:0033415', 'Cardiac tamponade', 'MP:0008676', 'decreased interleukin-15 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216099, 'HP:0033415', 'Cardiac tamponade', 'MP:0010143', 'enhanced fertility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216100, 'HP:0033415', 'Cardiac tamponade', 'MP:0011399', 'increased endoneurial fluid pressure', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216101, 'HP:0033415', 'Cardiac tamponade', 'MP:0005087', 'decreased acute inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216102, 'HP:0033415', 'Cardiac tamponade', 'MP:0006052', 'cerebellum hemorrhage', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(216103, 'HP:0033415', 'Cardiac tamponade', 'MP:0004120', 'cardiac ischemia', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(216104, 'HP:0033415', 'Cardiac tamponade', 'MP:0001853', 'heart inflammation', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(216105, 'HP:0033415', 'Cardiac tamponade', 'MP:0020419', 'decreased cardiac muscle relaxation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(216106, 'HP:0033415', 'Cardiac tamponade', 'MP:0020001', 'decreased response to antigen', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216107, 'HP:0033415', 'Cardiac tamponade', 'MP:0014029', 'increased respiratory epithelial chloride transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216108, 'HP:0033415', 'Cardiac tamponade', 'MP:0005257', 'abnormal intraocular pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216109, 'HP:0033415', 'Cardiac tamponade', 'MP:0030938', 'abnormal reticulophagy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216110, 'HP:0033415', 'Cardiac tamponade', 'MP:0008568', 'abnormal interleukin secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216111, 'HP:0033415', 'Cardiac tamponade', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(216112, 'HP:0033415', 'Cardiac tamponade', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
